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Alzheimer’s disease (AD) is the most common form of dementia with the 
characteristic symptom of progressive memory impairment. This is thought to be 
underpinned by the primary pathological features of neuronal and synaptic loss. 
The Group I p21-activated kinases (PAKs) are involved in regulating neuronal 
structure, which is crucial for the generation and maintenance of neuronal 
connections and functional signal transmission. Interestingly, evidence suggests 
that PAK levels are reduced in the brains of AD patients. The potential 
consequences of this for neuronal function will largely depend upon the roles 
PAKs play in neuronal physiology, the understanding of which is still being 
developed. 
Synaptic plasticity is widely considered to underlie the cellular mechanisms of 
memory, and so has been the focus of extensive study in trying to understand the 
causes of cognitive impairment in AD. We studied the role of PAKs in the long-
term potentiation (LTP) form of synaptic plasticity in acute hippocampal rat slices. 
We found that treatment of slices with IPA-3, a pharmacological PAK inhibitor, 
blocks LTP. However, another PAK inhibitor - FRAX486 - does not. As PAKs 
regulate cellular morphology, we stimulated synapse growth in cultured 
hippocampal neurons and examined the size of dendritic spines in the presence 
and absence of the PAK inhibitors. Consistent with our electrophysiology data, we 
found that IPA-3-treated neurons showed marked reductions in size, and 
FRAX486-treated neurons and controls did not. These observations suggest that 
IPA-3 and FRAX486 act differently on PAK function and that PAKs may have an 
influence on steps in the signalling cascade that triggers LTP. Further 
characterisation of the physiological roles PAK proteins play in neuronal function 
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Chapter 1 – Introduction 
1.1 Dementia and aberrant protein aggregates 
1.1.1 The epidemiology of dementia 
Dementia is a syndrome characterised by a progressive deterioration in memory 
and higher cognitive functions such as reasoning, planning, language, and is 
usually accompanied by alterations in mood and behaviour (Johns & Johns, 
2014). According to the World Alzheimer Report 2015, there were 46.8 million 
people living with dementia worldwide, but this number is expected to reach 
approximately 132 million in 2050 (Ali et al., 2015). As dementia is a condition 
which leads to a gradual loss of the patients’ ability to execute everyday activities 
on their own, the worldwide cost of dementia is considerable and it is expected to 
increase from $818 billion US dollars in 2015 to $2 trillion US dollars in 2030 (Ali 
et al., 2015).   
In addition to the economic cost, the main risk factor associated with the disease 
is age; the prevalence of this disease increases from approximately 6% in 65 to 
69-year-old cohort, to 20% in 85 to 89-year-olds, and 40% in 90 to 94-year-olds 
(Corrada et al., 2010; Ebly et al., 1994; Fiest et al., 2016). It has been reported 
that the growing number of people aged 65 and older is a major cause of the 
predicted prevalence of dementia (Prince et al., 2016). As old age is a risk factor 
for dementia, and with an ‘ageing population’, it is clear that dementia is a growing 
public health concern globally. Therefore, developing a better understanding of 
neuropathology in the search of better therapeutics is of critical importance. 
 
1.1.2 Unifying dementia: protein aggregates 
There are various types of dementia and they are classified according to clinical 
and neuropathological features. The most common type of dementia is 
Alzheimer’s disease, accounting for approximately two-thirds of all cases, followed 




The different aetiologies of dementia have been characterised by their 
neuropathology as well as their clinical features. Interestingly, the majority of these 
disorders share a central pathological phenotype which is defined by aberrant 
aggregation of different misfolded proteins. It is thought that the presentation of 
the different types of dementia depends on the amount and localisation of protein 
aggregates in the brain. However, the mechanisms underlying the pathological 
effects of protein aggregates – and whether they share similar molecular 
mechanisms – is currently unknown. Therefore, protein aggregation per se might 
be a causal factor that leads to degeneration. 
1.2 Dementia with Lewy bodies and Alzheimer’s disease – distinct diseases 
with shared aberrant protein aggregates 
1.2.1 Pathophysiology of Dementia with Lewy bodies 
Dementia with Lewy bodies (DLB) is one of the various types of dementia. This 
type of dementia accounts for approximately 4% of the dementia cases diagnosed 
in primary care, but its prevalence increases to 7% when diagnosed by specialists 
in secondary care (Vann Jones & O’Brien, 2014). The core clinical features of DLB 
include alterations in cognition and attention, recurrent visual hallucinations, motor 
symptoms which occur in later stages of the disease, and rapid eye movement 
sleep disorder, in addition to progressive memory loss (McKeith et al., 2017).  
The hallmark pathological feature of this neurodegenerative disorder is the 
presence of Lewy bodies and Lewy neurites, which are intracellular inclusions 
composed of misfolded proteins (Spillantini et al., 1997). The key protein found in 
Lewy bodies is α-synuclein, a presynaptic 140-amino-acid protein abundantly 
expressed in the brain and encoded by the SNCA gene. The aggregated α-
synuclein forms oligomers and insoluble unbranched filaments which have a 
cross-β pattern characteristic of amyloid proteins (Serpell et al., 2000); whereas 
under physiological conditions α-synuclein has been found to be a “natively 
unfolded” monomeric protein (Weinreb et al., 1996). This protein has a critical role 




SNCA gene or increases in SNCA gene dosage lead to Parkinson’s disease (PD) 
and DLB (Goedert et al., 2013). Furthermore, even though PD is predominantly 
associated with motor symptoms, development of dementia is common in 
advanced cases of this disease due to the progressive deposition of abnormal 
protein aggregates reaching the neocortex (H. Braak et al., 2003). Therefore, 
cognitive problems observed in DLB and in advanced cases of PD are probably 
caused by neurodegeneration produced by α-synuclein aggregation in the 
neocortex. 
1.2.2 Pathophysiology of Alzheimer’s disease 
In the case of Alzheimer’s disease (AD), patients usually present with a history of 
memory loss, inability to generate or understand written and spoken language, 
decreased ability to perform daily tasks, and neuropsychiatric symptoms such as 
mood disorders. The majority of AD cases have a late onset form of the disease 
referred to as sporadic AD, whereas a small proportion of cases (~1%) develop 
an inherited form of the disease with early onset referred to as familial AD. 
Although most of the cases are sporadic, the pathological and clinical findings are 
similar in both types of AD. The defining pathological signs of AD are senile 
plaques, neurofibrillary tangles, neuronal death and synaptic loss (Serrano-Pozo 
et al., 2011). Senile plaques consist mainly of extracellular amyloid β (Aβ) 
deposits, while neurofibrillary tangles (NFTs) consist of intracellular deposits of 
hyperphosphorylated tau. 
The Aβ peptide is produced from the cleavage of amyloid precursor protein (APP). 
The function of APP has not been elucidated, but it is thought to be involved in cell 
proliferation, differentiation, neurite outgrowth, synaptogenesis and synaptic 
plasticity (U. C. Müller et al., 2017). As shown in Figure 1.1, APP processing is 
initiated by various enzymes resulting in pathways yielding different fragments. In 
the amyloidogenic pathway, APP is cleaved by -secretase into an intracellular 
C99 fragment and the extracellular soluble APPβ fragment (sAPP). Next, -




(D. J. Selkoe et al., 1996). In the physiological non-amyloidogenic pathway, APP 
is cleaved into an intracellular fragment C83 and an extracellular soluble APPα 
(sAPP) by -secretase. Afterwards, C83 is cleaved into other fragments, P3 and 
AICD by -secretase (Dennis J. Selkoe, 1991). 
The enzyme -secretase is part of both the amyloidogenic and non-amyloidogenic 
pathways, and it is an enzymatic complex composed of presenilin1 (PS1) or PS2, 
nicastrin, presenilin enhancer 2 (PEN-2) and anterior pharynx-defective 1 (Aph-
1). The cleavage of APP is crucial for the pathological mechanisms of the disease 
as mutations in APP, PS1 and PS2 genes lead to  early onset familial AD (Dennis 
J. Selkoe, 1991). These mutations alter APP processing resulting in increased 
production of different forms of A that range from 39 - 42 amino acids and tend 
to aggregate to form dimers, oligomers and fibrils, each with different levels of 
toxicity (Borchelt et al., 1996). 
In the case of neurofibrillary tangles, their main component tau is an axonal 
microtubule-associated protein which binds and stabilises microtubules thereby 
supporting axonal transport. Under physiologically normal conditions tau is 
natively unfolded, however, increased phosphorylation of tau diminishes its affinity 
to microtubules. It has been suggested that tau hyperphosphorylation promotes 
aggregation, as it precedes the formation of NFTs, and these pathological 
accumulations spread through the brain as the disease progresses (F. Braak et 
al., 1994); however, the mechanism by which tau mediates toxicity remains 
unclear. Tau deposits are not exclusive to AD, as they are also characteristic of 
neurodegenerative diseases called tauopathies, such as frontotemporal dementia 
with parkinsonism-17, progressive supranuclear palsy, sporadic corticobasal 
degeneration, agyrophilic grain disease, and Pick disease (V. M.-Y. Lee et al., 
2001). Some of these diseases are caused by mutations in the tau encoding 
MAPT gene, and mutations within the microtubule-binding domain have been 
shown to enhance aggregation (Hong et al., 1998; S.  Barghorn et al., 2000). 




central not only to AD pathogenesis but in other neurodegenerative disorders as 
well.  
Aβ come in Aβ40 and Aβ42 isoforms. Aβ42 is more hydrophobic than Aβ40 and 
therefore more likely to bind to the cell membrane and form aggregates (Iljina et 
al., 2016).  The ratio of Aβ40 to Aβ42 is normally around 9:1 but the ratio of Aβ42 
is increased in some early onset forms of AD (Scheuner et al., 1996).  An 
increased ratio of Aβ42 has been shown to correlate with toxicity in vitro and in 
vivo (Kuperstein et al., 2010; Pauwels et al., 2012). 
The Aβ42 toxicity is linked with the disrution of cell membrane and bilayer 
disruption which are generated by secondary nucleations (aggregations of the 
primary oligomers) (Michaels et al., 2020). Flagmier et al. show that Aβ42 bilayer 
disrution correlates linearly with the amount of oligomers generated through 
secondary nucleations (Flagmeier et al., 2020). 
De et al. found that small Aβ42 aggregates are more inhibited by antibodies at the 
C-terminal region but larger aggregates are more effective at causing an 
inflammatory response (De et al., 2019). The larger aggregates are inhibited by 
antibodies targetting the N-terminal region. 
Aβ and α-syn have been found in vitro to form hetero-oligomers that promote the 
aggregation of each other (Chia et al., 2017). Bassil et al. found that mice injected 
with α-syn preformed fibrils accelerated Aβ deposits (Bassil et al., 2020). They 
also found that Aβ deposits promoted α-syn seeding in mice injected with α-syn 
preformed fibrils. 
There is evidence that α-syn propagates from cell to cell through a process similar 
to prions (Jucker & Walker, 2018). Prions are misfolded proteins that induce other 
proteins to misfold in the same way causing the misfolded protein to further 
replicate. Lau et al. found that α-syn propagates similarly to prions by 
conformational templating (Lau et al., 2020). They demonstrated this through the 




showed that the induced aggregates maintained their respective distinct 
biochemical and conformational properties. The preservation of these properties 
is a key feature of prion-like replication. 
α-syn forms both nontoxic and toxic forms (type A, type B) oligomers (Cremades 
et al., 2012) which have similar sizes and morphologies. However the toxic form 
includes lipophilic elements that encourage a strong membrane interactions which 
disrupt cellular function and lipid bilayers (Fusco et al., 2017). 
In summary, multiple lines of evidence suggest that different protein aggregates 
lead to loss of memory function in various diseases. One potential mechanism 
underlying the shared toxicity of different protein aggregates may be the 
similarities between their oligomeric species (Kayed et al., 2003). Indeed, 
mounting evidence suggests that small aggregates known as oligomers mediate 
neuronal dysfunction (Bucciantini et al., 2002; Hartley et al., 1999; Lambert et al., 
1998; Lashuel et al., 2002). However, it is necessary to explain how memory 
functions under normal physiological circumstances before attempting to 





Figure 1.1 Schematic diagram of Amyloid Precursor Protein (APP) processing pathways. 
Left: the non-amyloidogenic pathway APP cleavage is mediated by α-secretase and γ-secretase. 
This pathway precludes the production of Aβ as the enzymes involved produce a smaller fragment 
(P3). Right: in the amyloidogenic pathway, the cleavage of APP by β-secretase and γ-secretase 
results in the production of Aβ. AICD, amyloid precursor protein intracellular domain; sAPPα, 
soluble amyloid precursor protein-α; sAPPβ, soluble amyloid precursor protein-β.  
 
1.3 Memory as a cognitive function 
1.3.1 Definitions of memory 
There are different types of memory; the current subdivisions of memory depend 
on timing: short-term memory and long-term memory. Short-term memory is 
measured in seconds to minutes and it includes sensory memory and working 
memory (Nelson, 2008). Sensory memory is a mental representation of the 
sensory characteristics of a stimulus while working memory is the storage of 
information necessary to perform tasks. The second type of memory is long-term 
memory, which is also divided into explicit (declarative) and implicit (non-




divisions depend on the contents of memory; explicit memory includes memories 
that are recalled consciously, such as facts and events, while implicit memory 
includes procedural memory, which is the ability to remember sequences of motor 
movements such as riding a bicycle. The distinction between these types of 
memory allows for a focused analysis of the processes associated with each type.  
Implicit memory is characterized by the nonconscious recall of motor skills. This 
type of memory includes procedural (skills and habits), priming, associative 
learning (classical and operant conditioning), and non-associative learning 
(habituation and desensitisation). The areas of the brain associated with these 
forms of memory are the cerebellum and basal ganglia (Squire, 1992). Explicit 
memory processes are supported by neural circuits and systems in the medial 
temporal lobe and structures such as the hippocampus, subiculum, and entorhinal 
cortex. Explicit memory, in contrast to implicit memory, involves conscious recall 
of personal experiences and knowledge about the world (Tulving, Endel 
Donaldson, 1972). Explicit memory is in turn subdivided into episodic and 
semantic memory; the first type consists of personal experiences involving places, 
time, and people while the latter represents the knowledge of concepts and facts 
(Figure 1.2).  
 
Figure 1.2 Classification of long-term memory. The types of long-term memory are based on 
the type of information that is stored. Explicit memory involves storage of information that can be 





1.3.2 The role of the hippocampus in learning and memory 
The distinction between explicit and implicit memory was suggested by studies of 
patients with damage to specific brain regions. An important case study was that 
of Henry Molaison (H.M.) who underwent a bilateral medial temporal lobectomy in 
1953 to prevent his frequent epileptic seizures. The surgeons removed a large 
part of both his hippocampi and severed its connections to associated limbic 
structures, such as the amygdala. After his surgery H.M.’s seizures were 
significantly reduced, however, he also did not remember events in his life that 
occurred one year before his surgery and he lost the ability to form new episodic 
memories. Multiple tests were performed on H.M. to assess his memory (Scoville 
& Milner, 1957). The results of those tests suggested that H.M. could still 
remember details such as numbers or a few words at a time, at least for a short 
amount of time if he repeated them; and he could perform progressively better at 
motor tasks without remembering that he had tried to perform the task before. 
These tests suggested that his short-term and procedural memory were intact. 
Furthermore, H.M.’s older memories from one year before his surgery and his 
short-term memory were intact. Therefore, this clinical case led to the discovery 
that the hippocampus has a time-dependent role in information encoding and 
retrieval of memories (M. A. Lynch, 2004) and that it might be responsible for 
converting short-term memories into long-term memories. 
Further evidence supporting the role of the hippocampus in explicit memory came 
from other clinical cases in which the severity of damage to the hippocampal 
formation corresponded to the level of memory impairment (Rempel-Clower et al., 
1996). One of the cases was that of patient R.B. who exhibited anterograde 
amnesia after he suffered an ischaemic episode which specifically damaged the 
entire CA1 region of the hippocampus (Amaral et al., 1986). Therefore, findings 
from patients who exhibited bilateral damage specific to the hippocampus validate 
the function of the hippocampus in declarative memory. However, the underlying 





1.3.3 The hippocampal anatomy 
The hippocampus is a structure located in the medial temporal lobe. It consists of 
circuits of neurons with specific inputs coming from surrounding cortical areas. 
The arrangement of these circuits is well known: the inputs to the hippocampus 
come mainly from the entorhinal cortex to form synapses with neurons in the 
dentate gyrus (DG) and area CA3 (Cornus Amoni 3); the DG neurons send their 
axons to form connections with CA3; then CA3 neurons send axons to form 
synapses with both the CA1 region, and the contralateral hippocampus in the 
adjacent hemisphere; CA1 neurons send axons to the subiculum; finally the latter 
sends output axons to the entorhinal cortex. As the neuroanatomical organisation 
of the hippocampus connects the DG with CA3 and CA3 to CA1, it is referred to 
as the trisynaptic pathway. 
The arrangement of neurons in the hippocampus is layered. The first layer is 
formed by afferent and efferent fibres, interneurons and basal dendrites. This layer 
is called hilus in the DG, and stratum oriens in CA (van Strien et al., 2009). The 
adjacent layer is referred to as the cell layer because it is where neuronal bodies 
are situated. The cell layer is called the granule layer in the DG, and the pyramidal 
cell layer in CA, because the main types of neurons in these regions are granule 
neurons and pyramidal neurons respectively. Pyramidal neurons possess two 
different dendritic trees formed by basal and apical dendrites. Basal dendrites are 
located in the stratum oriens, and apical dendrites are located stratum radiatum, 
which extend into the stratum lacunosum-moleculare. 
The well-defined arrangement of layers in this area of the brain is advantageous 
for the study of the physiological basis for learning and memory. The reason for 
this advantage is that we know that if we stimulate neurons in one area, in CA3 
for example, we observe a response from the neurons in CA1, then the synaptic 
efficacy of the responses elicited can be compared under different experimental 
conditions. In this thesis, synaptic transmission was assessed using extracellular 
field recordings from the stratum radiatum in the CA1 region in rat hippocampal 





1.4 Molecular mechanisms of memory 
Memory function is underpinned by the ability of neurons to transmit information. 
This information transfer occurs at synapses which are anatomical regions that 
connect one neuron to the next. There are two main types of synaptic 
transmission: electrical and chemical. Electrical synapses are formed by gap 
junctions, which are clusters of intercellular channels, creating a bridge between 
the interior of adjacent neurons allowing the flow of electric current, small 
metabolites and signalling molecules (Bennett & Zukin, 2004). Conversely, in 
chemical synapses information is transferred from the presynaptic neuron to the 
postsynaptic neuron through the release of neurotransmitters. Upon the arrival of 
action potentials at the presynaptic terminal, voltage-gated calcium channels are 
activated, allowing calcium ions to flow into the presynaptic site. The increased 
concentration of calcium ions allows the fusion of vesicles containing 
neurotransmitters with the presynaptic plasma membrane, thereby releasing 
neurotransmitters into the space between the presynaptic and postsynaptic sites. 
Neurotransmitters determine the opening or closing of ion channels which alter 
the synaptic potential of the postsynaptic neuron. The effect on the synaptic 
potential is usually excitatory or inhibitory, with the main excitatory 
neurotransmitter in the CNS being the amino acid L-glutamate and the main 
inhibitory neurotransmitter being γ-aminobutyric acid (GABA). These excitatory 
and inhibitory neurotransmitters bind to different types of receptors, glutamate 
receptors and GABA receptors. 
1.4.1 Glutamate receptors  
Depending on their mechanisms of action glutamate receptors are divided into two 
groups: ionotropic and metabotropic glutamate receptors. The first type, ionotropic 
receptors are ligand-gated ion channels; when glutamate binds to these receptors 
their ion channel opens and permits the movement of cations into the cell. The 




receptors which mediate the activation of proteins or other ion channels through 
secondary messengers.  
Ionotropic glutamate receptors are classified into four classes according to the 
synthetic agonists that activate each receptor and structural homology: α-amino-
3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA), L-α-kainic acid (kainate), 
δ receptors, and N-Methyl-d-aspartic acid (NMDA) receptors (Traynelis et al., 
2010).  
1.4.1.1 AMPA receptors 
AMPA receptors (AMPARs) are tetrameric receptors, that is, their structure 
consists of four protein subunits assembled together to form the receptor 
(Rosenmund et al., 1998). There are four types of AMPAR subunits called GluA1 
to GluA4 which are encoded in different genes (Anggono & Huganir, 2012). 
AMPARs are composed of different combinations of subunits forming heteromeric 
assemblies (containing 2 or more different subunits). Each subunit possesses an 
extracellular N-terminal domain, a ligand-binding domain, transmembrane 
domains, and an intracellular C-terminal domain (Hollmann et al., 1994). 
Furthermore, AMPAR subunit composition confers different channel properties, 
ion selectivity and trafficking properties; therefore, the structural diversity of these 
receptors generates functional diversity (Greger et al., 2017). 
In the adult hippocampus, two forms of AMPARs are thought to predominate: 
GluA1/GluA2 heteromers and GluA2/GluA3 heteromers (Lu et al., 2009; Wenthold 
et al., 1996). The majority of GluA2-containing AMPARs are impermeable to Ca2+, 
due to the fact that these subunits contain a positively charged arginine (R) residue 
at the glutamine (Q)/R site located in the pore-lining region M2 (Sommer et al., 
1991). The change of residue at the Q/R site results from a post-transcriptional 
modification of the genetically encoded adenosine into inosine by adenosine 
deaminases acting on RNA (ADAR) enzymes, producing the codon for arginine 




Alternatively, when GluA2 mRNAs are unedited so that a neutral glutamine 
residue is present at the Q/R site, the receptor becomes Ca2+ permeable which 
increases their channel conductance. This characteristic of the GluA2 subunit 
makes it a crucial determinant of AMPAR function (S. Cull-Candy et al., 2006). 
AMPARs are permeable to Na+ and K+, and the excitatory postsynaptic currents 
(EPSCs) mediated by these receptors peak within approximately one hundred 
microseconds and decay within a few milliseconds (Colquhoun et al., 1992). 
Therefore, the activation and deactivation kinetics of AMPARs makes them key 
mediators of fast excitatory signal transmission.  
1.4.1.2 NMDA receptors 
Similar to AMPARs, NMDA receptors (NMDARs) are tetramers, with each subunit 
possessing an N-terminal domain, a ligand-binding domain, a transmembrane 
domain, and a C-terminal domain. NMDARs subunits belong to 3 subfamilies 
which include the GluN1 subfamily (GluN1 subunit), the GluN2 subfamily 
(GluN2A, GluN2B, GluN2C and GluN2D subunits), and the GluN3 subfamily 
(GluN3A and GluN3B subunits) (Traynelis et al., 2010). The NMDAR 
heterotetramers contain two obligatory GluN1 subunits together with two GluA2 or 
GluA3 subunits or GluA2 and GluA3 subunits combined (Ulbrich & Isacoff, 2008). 
This variability of the subunit composition of NMDAR subtypes contributes to the 
distinct physiological properties and functions (S. G. Cull-Candy & Leszkiewicz, 
2004). 
The properties conferred by the various NMDAR subunits make them 
distinguishable from the other types of ionotropic receptors. First, in addition to 
glutamate binding, two conditions are required for the channel ion to open: the 
binding of the cofactor glycine or D-serine (Kuryatov et al., 1994), and membrane 
depolarization need to occur. The reason why membrane depolarization is 
necessary is that at resting membrane potential the NMDAR channel is blocked 
by the presence of Mg2+ inside the pore of the channel (Mayer et al., 1984). When 
glutamate is released AMPARs activate producing depolarization which causes 




postsynaptic neuron. Second, they are highly permeable to Ca2+ as well as to Na+ 
and K+. Third, NMDAR-gated currents have slow kinetics, of around a few hundred 
milliseconds (Lester et al., 1990). Finally, the function of these receptors is 
modulated by many small molecules which bind to specific subunits, allowing 
researchers to pharmacologically distinguish receptor subtypes (Paoletti et al., 
2013). 
Moving on now to consider the contribution of NMDARs and AMPARs to synaptic 
transmission, the release of glutamate activates both types of receptors producing 
EPSC consisting of an early component and a late component. The fast 
component is mediated by AMPARs while the slow component is mediated by 
NMDARs (Collingridge et al., 1988; Forsythe & Westbrook, 1988; Hestrin et al., 
1990). In addition, both of these types of receptors are widely expressed at 
individual synapses in hippocampal neurons (Bekkers & Stevens, 1989). These 
findings support the idea that AMPARs and NMDARs are fundamental to neuronal 
circuit function. 
1.4.1.3 Metabotropic glutamate receptors 
mGlu receptors belong to the family of GTP-binding protein-coupled receptors 
which activate signalling cascades indirectly via second messengers. The 
structure of these receptors consists of a large extracellular amino-terminal 
domain which contains the binding site for glutamate, seven-transmembrane 
domains, and an intracellular carboxyl-terminal domain which activates G-proteins 
(Niswender & Conn, 2010). The classification of mGlu receptors subtypes is based 
on shared second messengers, sequence homology and sensitivity to 
pharmacological agents (Pin & Duvoisin, 1995). Group I consists of mGluR1 and 
mGluR5, Group II consists of mGluR2 and mGluR3, while Group III consists of 
mGluR4, mGluR6, mGluR7 and mGluR8. These receptors are widely expressed 
in neurons and their synaptic location is associated with their specific groups: 
Group I mGlu receptors are found in postsynaptic sites, Group II mGlu receptors 
are found in presynaptic and postsynaptic sites, while Group III mGlu receptors 




that mGlu receptor activation leads to the modulation of a broad range of ion 
channels and signalling proteins (Anwyl, 1999). Thus, mGlu receptors have many 
physiologic roles making them key players in the modulation of neuronal 
excitability and synaptic transmission. 
1.4.2 GABA receptors 
GABARs are activated by the main inhibitory neurotransmitter in the adult brain. 
GABARs exist as ionotropic and metabotropic, whose activation mediates 
inhibitory postsynaptic potentials (IPSPs) composed of fast responses and slow 
responses (Connors et al., 1988). Ionotropic GABAARs consist of pentameric 
ligand-gated ion channels permeable to chloride ions (Cl-) that mediate the fast 
component of IPSPs (Bormann, 1988). Activation of GABAARs leads to the influx 
of Cl- and results in hyperpolarisation in mature neurons. It has been reported that 
another class of ionotropic GABA receptor exists, these are termed GABACR and 
they are considered to be variants of GABAARs as they share sequence homology 
and they are also permeable to Cl- (Bormann & Feigenspan, 1995). Conversely, 
metabotropic GABABRs are G-protein-coupled receptors that share sequence 
similarities with mGlu receptors (Kaupmann et al., 1997). GABABRs mediate the 
slow component of IPSPs via second messengers and their associated enzymes 
acting on Ca2+ and K+ channels (Bormann, 1988). Therefore, GABA receptors are 
essential for the regulation of neuronal excitability. 
In summary, a wide range of excitatory and inhibitory receptors are involved in 
processing and integrating neuronal signals. This information processing 
mediated by receptors contributes to the conversion of neuronal signals into long-
term changes in synaptic strength (Voglis & Tavernarakis, 2006). Long-term 
changes in synaptic strength might underpin the ability of neurons for learning and 
memory. However, we will only focus experimentally on AMPARs. Thus, the next 
section describes the mechanisms that are thought to be involved in the regulation 





1.4.3 Synaptic plasticity 
Over 100 years ago, Santiago Ramón y Cajal suggested that learning relies on 
changes in the strength of synaptic networks (Mayford et al., 2012). This idea was 
developed further by Donald Hebb who proposed that if a neuron is able to activate 
a neighbouring neuron repeatedly, eventually it will become more efficient at 
activating that neuron by an unknown process (Hebb, 1949). Hebb’s postulate is 
a potential mechanism by which information is stored. Accordingly, the repetition 
of a signalling pattern triggered after an experience would lead to the modification 
of neural circuits involved, producing long term changes in patterns of neural 
transmission which create a physical representation of the experience (Bliss & 
Collingridge, 1993). Synaptic plasticity shares characteristics with the mechanism 
described by Hebb, therefore it has been extensively studied in relation to learning 
and memory. 
Synaptic plasticity is the ability of neuronal connections to adapt to different activity 
patterns to increase or decrease the intensity of their signal transmission. Different 
forms of synaptic plasticity have been observed, but the most studied forms of 
synaptic plasticity are long-term potentiation (LTP) and long-term depression 
(LTD). LTP was first identified in rabbits’ hippocampi by Bliss and Lomo by in 1973; 
they found that a brief train of high-frequency stimulation produced a long-lasting 
increase in the magnitude of neuronal responses (Bliss & Lømo, 1973). Their 
results demonstrated that activity-dependent changes in synaptic function resulted 
in increased synaptic efficacy specific to the neurons forming synapses with the 
stimulated neurons. Conversely, long-term depression (LTD) is the weakening of 
neuronal responses which results from low-frequency stimulation (G. S. Lynch et 
al., 1977). As both LTP and LTD result in long-lasting changes in synaptic efficacy 
produced by coincident pre- and post-synaptic signalling, they are useful 
experimental models to study memory encoding and storage.  
1.4.3.1 Long-term potentiation  
Synaptic strength is defined by the amplitude of the postsynaptic potentials 




neurons. Synaptic activation during high-frequency stimulation triggers a 
sequence of biochemical reactions that result in a long-lasting increase in synaptic 
strength (Figure 1.3B). LTP has been observed in many different synapses and 
the molecular cascades that are initiated by it are also different depending on the 
synapses and circuits that are stimulated (Malenka & Bear, 2004). This thesis 
focuses on mechanisms triggered by the NMDAR-dependent form of LTP in 
synapses formed by Schaffer collaterals and pyramidal neurons in the CA1 area 
of the hippocampus.  
LTP is a multi-step process that consists of at least two phases: early-LTP (E-LTP) 
and L-LTP (L-LTP). E-LTP consists of events leading to LTP induction. Usually 
triggered by high-frequency stimulation (HFS) or tetanus which activates 
biochemical processes. The activation of this process increases synaptic strength 
during the first 1 to 3 hours (Baltaci et al., 2019). Whereas, L-LTP or LTP 
maintenance is triggered by repeated stimuli and consists of the biochemical 
events produce a sustained increase in synaptic efficacy lasting from hours to 
weeks, or months (Baltaci et al., 2019).  
Before LTP induction, a single stimulus releases glutamate which binds to 
AMPARs, metabotropic glutamate receptors and NMDARs present on the 
postsynaptic membrane (discussed in the previous section). However, NMDARs 
are only weakly activated because of the Mg2+ blocking the NMDAR channel. It is 
during and just after HFS when glutamate release from axon terminals is 
enhanced which activates AMPARs and therefore depolarises the postsynaptic 
neuron. This removes the Mg2+ block, allowing Ca2+ influx through NMDARs which 
depolarises the membrane further. Although the intracellular Ca2+ rise is short-
lasting (a few seconds), it is a requirement for the induction of LTP as it triggers 
the activation of Ca2+-dependent protein kinases such as Calcium-calmodulin 
(CaM), CaM kinase II (CaMKII), and protein kinase C (PKC) (Lisman et al., 2012; 
Malenka & Bear, 2004; Malinow et al., 1989). CaMKII is a key component of the 
LTP signalling cascade as its pharmacological or genetic deletion results in 




Yamagata et al., 2009). In addition, PKC was found to contribute to LTP as PKC 
inhibitors block LTP induction if they are applied following the tetanus, whereas 
the application of PKC activators such as phorbol esters induces synaptic 
potentiation similar to LTP (Bliss & Collingridge, 1993a; Hu et al., 1988). It has 
been proposed that CaMKII and PKC are necessary for LTP because these 
kinases phosphorylate the C-tail of the GluA1 AMPAR subunit (Barria et al., 1997; 
Boehm et al., 2006; Mammen et al., 1997). The phosphorylation of this AMPAR 
subunit increases the conductance of the receptor, which is important for 
potentiation of synaptic strength (Lee et al., 2000). Then, LTP induction results 
from molecular cascades trigged by Ca2+-dependent proteins leading to the 
modification of AMPARs. The phosphorylation of AMPARs is also a marker for 
their delivery and insertion into the synaptic membrane, which increases the 
number of receptors at the postsynaptic site (Hayashi et al., 2000; Shi et al., 1999). 
Finally, AMPAR phosphorylation and AMPAR trafficking to the postsynaptic cleft 
results in the sustained potentiation of the postsynaptic glutamatergic response. 
The changes in AMPAR trafficking is thought to produce an initial increase in 
synaptic strength lasting 30–60 min, sometimes referred to as LTP expression (R 
C Malenka & Bear, 2004).  
In the case of L-LTP, an increased number of tetanisations initialise molecular 
mechanisms that enable long-lasting increase in strength. This phase requires 
posttranslational protein modifications, de novo protein synthesis and gene 
transcription (Abraham & Williams, 2003; M. A. Lynch, 2004; R C Malenka & 
Bear, 2004). The signalling pathways involved in L-LTP are initiated by NMDAR 
stimulation, Ca2+ influx. Then CaM stimulates adenylate cyclase, increasing 
cyclic AMP (cAMP) levels (Nguyen & Woo, 2003). Increased cAMP in turn 
activates protein kinase A (PKA), which moves to the nucleus and activates the 
cAMP response elements-binding protein (CREB) following its activation 
(Nguyen & Woo, 2003). CREB and other proteins such as mitogen-activated 
protein kinase (MAPK) regulate the expression of transcription factors and gene 
expression. Those genes include targets such as  the immediate early gene 




synthesis of proteins necessary for the persistence of synaptic potentiation and 
changes in spine morphology (Baltaci et al., 2019; R C Malenka & Bear, 2004; 
Thomas & Huganir, 2004).  
LTP has been observed in many different synapses and the molecular cascades 
that are initiated by it are also different depending on the synapses and circuits 
that are stimulated (Malenka & Bear, 2004). This thesis focuses on mechanisms 
triggered by the NMDAR-dependent form of LTP in synapses formed by Schaffer 
collaterals and pyramidal neurons in the CA1 area of the hippocampus. 
1.4.3.2 Long-term depression 
In this form of plasticity, postsynaptic potentials remain decreased in magnitude 
for hours following prolonged periods of repetitive stimulation (Figure 1.3C). Low-
frequency stimulation induces a form of LTD in the area CA1 of the hippocampus 
that is dependent on NMDAR activation (Dudek & Bear, 1992). The activation of 
NMDARs causes small increases in intracellular postsynaptic Ca2+, triggering the 
activation of phosphatases (Mulkey et al., 1994) which mediate dephosphorylation 
and removal of AMPARs from the postsynaptic membrane. This results in the 
weakening of postsynaptic responses.  
Studies investigating synaptic plasticity mechanisms have provided evidence for 
the link between learning and LTP and LTD. For instance, experiments using rats 
showed that learning produces an enhancement of synaptic efficacy in the CA1 
region of the hippocampus, and other biochemical changes associated with LTP 
induction (Whitlock et al., 2006), while inhibiting sustained potentiation leads to 
loss of long-term spatial memory without affecting short-term memory (Pastalkova 
et al., 2006). In terms of LTD, deficits in visual recognition memory have been 
observed following the blockade of AMPAR internalisation, a necessary step for 
the expression of LTD (Griffiths et al., 2008). Furthermore, it has been reported 
that hippocampus-dependent spatial learning is impaired when LTD is blocked, 




indicate that understanding the regulation of synaptic strength might be crucial to 






Figure 1.3 The hippocampus as an experimental model for studying synaptic plasticity. 
A. Left: A schematic diagram of the rodent brain showing both c-shaped hippocampi. Right: 
Schematic diagram of a transverse hippocampal slice showing the major excitatory pathways; 
the Perforant Path (PP) fibers terminate on granule cells (GCs) in the Dentate Gyrus (DG), then 
Mossy Fibers (MF) extend from GCs and terminate on CA3, and Schaffer Collateral (SC) fibers 
extend from CA3 to CA1. Responses elicited by electrically stimulating CA3 are measured in 
CA1 as field excitatory postsynaptic potentials (fEPSPs). B. Example of a typical LTP experiment 
induced by high-frequency stimulation (HFS; 100 Hz tetanus for 1 second). C. Example of a 
typical LTD experiment induced by low-frequency stimulation (LFS; 1 Hz stimulation for 15 
minutes). The traces on the top-right side of B and C depict fEPSPs taken at the times indicated 




1.5 Regulation of neuronal structure in physiological and pathological 
conditions 
1.5.1 Structural plasticity 
In the central nervous system, the main sites for excitatory transmission are 
dendritic spines, tiny protrusions of various sizes and shapes (Bourne & Harris, 
2008). They are classified in three groups according to their morphology; thin 
spines have a constricted neck and small heads, stubby spines have similar neck 
length and width, and mushroom spines have narrow necks and large heads 
(Tada & Sheng, 2006). Regarding the function of dendritic spines, it has been 
suggested that they may be involved in isolating and amplifying Ca2+ influx and 
Ca2+-dependent biochemical cascades (Bloodgood et al., 2009; W. Müller & 
Connor, 1991). Consequently, dendritic spines are considered to be key structures 
for synaptic transmission.  
Changes in neuronal morphology, such as the growth of new spines and 
remodelling of existing spines are referred to as structural plasticity. These 
structural changes have functional consequences as synapse formation, 
stabilisation, remodelling or elimination may result in altered connectivity (Caroni 
et al., 2012). Moreover, changes in synaptic connectivity are believed to be critical 
for learning. For instance, learning a motor skill task and exposure to an enriched 
environment where animals were exposed to novel sensory experiences 
promoted the formation of dendritic spines (Yang et al., 2009). In the same study, 
although only a small fraction of newly formed spines remained over weeks 
following training, the amount of newly formed spines correlated positively with the 
animal’s performance on the motor task. Similarly, other studies have shown that 
motor and sensory learning paradigms promote rapid dendritic spine formation 
and stabilisation (Hofer et al., 2009; Roberts et al., 2010; Xu et al., 2009).  
Interestingly, studies show that the induction of LTP is accompanied by structural 
changes in dendritic spines. Mounting evidence has shown that LTP induces 
dendritic spine growth, the formation of new spines, and PSD enlargement 




new protrusions and the growth of existing protrusions near the site of stimulation 
(Engert & Bonhoeffer, 1999; Maletic-Savatic et al., 1999). Furthermore, LTP-
inducing protocols promote the formation of new dendritic spines, some of which 
become stable and remain over periods of several days (De Roo et al., 2008). 
This indicates a relationship between synaptic plasticity and structural plasticity, 
however, any role either of these mechanisms plays in learning and long-term 
memory formation remains unclear. 
 
1.5.2 Regulation of actin dynamics 
Actin is a component of the cytoskeleton and it serves as an anchor that links 
scaffolding proteins and receptors to the cytoskeleton (Sheng & Pak, 2000). 
Structural plasticity is mediated by actin cytoskeleton rearrangements (Tada & 
Sheng, 2006). Actin exists in two forms: globular (G-actin) and filamentous (F-
actin), the former polymerizes to form a double-stranded helical F-actin (Matus et 
al., 1982). Dendritic spine morphology changes are induced by different signalling 
cascades that involve actin regulatory proteins. These cascades activate the Rho 
family of guanosine triphosphatases (GTPases), which are small molecular 
switches that are active while they are bound to GTP and inactive while they are 
bound to GDP.  
Regarding dendritic spine enlargement, the first steps of the mechanism 
correspond with events that trigger LTP. Glutamate release activates both 
AMPARs and NMDARs, which initiate calcium signals, that then activate CaMKII 
(Yamagata et al., 2009). Rho-GTPases, such as RhoA (Ras homolog family 
member A), and Cdc42 (Cell division cycle 42) have been found to become active 
following a protocol that induces spine enlargement, and this is inhibited after 
NMDAR inhibition (Hall, 2012). Additionally, RhoA and Cdc42 activation were 
partially suppressed (Hall, 2012), following CaMKII inhibition, which suggests that 
CaMKII relays activation signals through these Rho-GTPases. In contrast, RhoA 




LTP (from 30 seconds up to 2 minutes after stimulation), whilst Cdc42 inhibition 
diminished the sustained phase of structural LTP (more than 30 minutes after 
stimulation) (Hedrick et al., 2016; Murakoshi et al., 2011). This indicates that RhoA 
and Cdc42 mediate different phases of dendritic spine enlargement.  
Previous studies evaluating downstream effectors of Cdc42 and Rac1 suggest 
that serine/threonine kinases known as p21-activated kinases (PAKs) are 
important mediators of structural plasticity in dendritic spines (Hall, 2012; Manser 
et al., 1994). In mammals PAKs are divided into two groups of proteins based on 
their structural domains and their regulatory mechanisms: PAK1, PAK2, and PAK3 
are part of group I, while PAK4, PAK5 and PAK6 belong to group II. The six PAK 
isoforms have a regulatory domain on the N-terminal region and a kinase domain 
on the C-terminal region. In group I PAKs the regulatory domain contains a p21-
binding domain (PBD) or Cdc42/Rac Interactive binding (CRIB) domain, 
polyproline motifs and a autoinhibitory domain (AID) (Bokoch, 2003) , see Figure 
1.4 Whereas group II PAKs do not contain a defined AID, which is consistent with 
their activation processes being different than group I PAKs activation (Civiero & 
Greggio, 2018; Eswaran et al., 2008). Group I PAKs are usually activated when 
they are bound with active GTPases, whereas group II PAKs kinase domains are 
constitutively active, independently of GTPases.  
As can be seen in Figure 1.5, Group I PAKs exist as homodimers in their 
inactivated state, with the regulatory region (AID) of one PAK over the kinase 
domain of the other. This configuration blocks GTPase access to the PBD, 
preventing the activation of the two kinases of the homodimer (Bokoch, 2003). 
When GTP-bound GTPases, such as Cdc42 and Rac, bind to PAK homodimers 
the AID dissociates from the kinase domain, each of the two molecules undergoes 
conformational changes and autophosphorylation of the kinase domain, activating 
its activity towards downstream substrates (Bokoch, 2003; Manser et al., 1994). 
Once PAK is autophosphorylated, the active GTPase is released from the 
complex as the binding affinity of the activated kinase to the GTPase is reduced 




dephosphorylated, which switches PAK to its closed and inactive conformation 
(Zenke et al., 1999).  
Group I and II PAKs are expressed throughout the body, but some PAK isoforms 
have distinct expression patterns in humans and in mice. PAK1 is highly 
expressed in the brain, muscle and spleen; PAK2 is ubiquitously expressed; PAK3 
is predominantly expressed in the brain (Koth et al., 2014); PAK4 is expressed in 
several tissues, and it is highly expressed in the prostate, colon and testis (Abo et 
al., 1998); PAK5 is highly expressed in the brain (Pandey et al., 2002); whilst PAK6 
is highly expressed in the testis, prostate, brain, kidney and placenta (Arias-
Romero & Chernoff, 2008; F. Yang et al., 2001). The expression of PAKs in the 
central nervous system makes them excellent candidates for the study of their role 







Figure 1.4 p21-activated kinase structure. Group I PAKs have a PBD that overlaps with an AID, 
and a kinase domain that is 93% similar (Arias-Romero & Chernoff, 2008). Group II PAKs also 
contain an N-terminal PBD and a C-terminal kinase domain, but they lack motifs found in group I 
and this group similarity among its members is lower than that of group I PAKs. Both groups contain 





Figure 1.5 Mechanism for group I PAK GTPase-dependent activation. In their inactive form, PAKs 
exist as homodimers with the Autoinhibitory domain (AID) of one PAK protein overlapping the kinase 
domain of the second PAK protein, and vice versa. The homodimers dissociate following binding of an 
active RhoGTPase (Cdc42 or Rac1) to the p21-binding domain (PBD) of PAKs. The binding of the 
RhoGTPase leads to a conformational change that exposes the PAK activation loop allowing 
autophosphorylation. Then the RhoGTPase dissociates from its binding site, but kinase activity remains 
high as subsequent phosphorylation of various PAK residues allow PAK’s structure to remain in an 





In terms of the specific functions of PAK isoforms, studies targeting genetic 
deletions of specific PAK isoforms in  mouse models have elucidated distinct roles 
of individual PAK members on biological processes. PAK1, PAK3, PAK5 and 
PAK6 knock-out mice are viable, whereas knocking-out PAK2 and PAK4 in mice 
leads to embryonic lethality (Arias-Romero & Chernoff, 2008; Li & Minden, 2003; 
Meng et al., 2005; Qu et al., 2003). PAK1 knockout mice show normal brain 
anatomy, basal synaptic strength, presynaptic function, but hippocampal CA1 LTP 
is dramatically impaired and F-actin content was reduced (Asrar et al., 2009). Mice 
lacking PAK3 showed normal neuronal structure and F-actin content, however, 
the late-phase of LTP was impaired and CREB phosphorylation was reduced 
(Meng et al., 2005). Furthermore, double PAK1/PAK3 knockout mice showed 
impairments in brain growth postnatally, less complex neuronal morphology, LTP 
impairment, reduced amount of F-actin, and memory deficits (Huang et al., 2011). 
These findings indicate that PAK1 and PAK3 functions are redundant as individual 
PAK1 and PAK3 knockout mice do not show aberrant neuronal morphology.  
PAK4-null mouse embryos revealed that this isoform is necessary for axonal 
growth and neuronal development and that its absence resulted in embryonic 
lethality due to foetal heart defects (Qu et al., 2003). PAK5 knockout mice have 
no signs of gross abnormalities in tissues where PAK5 is usually expressed, which 
suggests that there might be functional redundancy between PAK5 and other PAK 
isoforms (Li & Minden, 2003). PAK6 knockout mice did not show an abnormal 
phenotype, whereas PAK5/PAK6 double knockout mice were found to have 
deficits in motor function and in learning and memory tests (Nekrasova et al., 
2008). 
In the central nervous system, PAK proteins have been found to be involved in the 
regulation of neuronal morphology, neuronal differentiation, brain development, 
dendritic spine maintenance, and synaptic activity. This is due to the broad range 




regulatory light chain (MLC) on Ser19, which promotes the formation of dendritic 
spines through the stabilisation of the actin network (Zhang et al., 2005). Other 
PAK substrates are also involved in cytoskeletal rearrangements, such as Filamin-
A which is an actin-binding protein important for cross-linking actin filaments and 
for connecting them to the cell membrane (Vadlamudi et al., 2002); and, PAK 
phosphorylates the regulatory component of actin-related protein (Arp) 2/3 
complex, which regulates actin nucleation and branching, inducing mammalian 
cell motility (Rane & Minden, 2014; Vadlamudi et al., 2004). Moreover, PAKs 
activates LIM kinase (LIMK), which in turn inactivates cofilin by phosphorylating it 
at Ser3. As cofilin is an actin-depolymerising protein, its inactivation facilitates 
actin polymerization (Arber et al., 1998; Koth et al., 2014; Yang et al., 1998).   
Different approaches have helped identify the steps in the signalling cascades 
where PAKs contribute to actin dynamics. Figure 1.6 shows that following 
activation of PAKs by Cdc42 or Rac1, PAK is able to phosphorylate LIM kinase 
(LIMK) which inactivates cofilin by phosphorylation (Cingolani & Goda, 2008a). 
Supporting evidence for this pathway comes from the finding that inhibiting PAKs 
resulted in decreased sustained volume change caused by glutamate uncaging 
(Hedrick et al., 2016; Murakoshi et al., 2011). These findings indicate that PAKs 
might be key mediators of dendritic structural plasticity. 
Interestingly, PAKs have also been found to have effects that are independent of 
their role in the regulation of actin dynamics. Studies on PAK1 knockout mice have 
demonstrated that PAK dysfunction restricts GABAergic synaptic transmission by 
modulating the release of the inhibitory neurotransmitter GABA through an 
endocannabinoid receptor-mediated signalling mechanism (Xia et al., 2016, 
2018).  
PAKs are crucial components of many signalling cascades and their role in 
plasticity should be investigated further. Of particular concern is that Hayashi et 
al. found that dominant negative PAK (dnPAK)-expressing transgenic animals 




impairments found in PAK1 and PAK3 knockout animals. This indicates a need to 
understand the specific role of PAKs in synaptic plasticity because of its 
involvement in learning and memory as well as how PAK dysfunction could be 







Figure 1.6 Molecular mechanism for spine morphology rearrangements. Following AMPAR 
and NMDAR activation, sodium permeates through AMPARs producing depolarization. This 
releases the magnesium block of the NMDAR ion channel. This receptor is permeable to sodium 
and calcium, which enter the spine. Calcium binds to calmodulin to activate CaMKII, which 
undergoes autophosphorylation and activates RhoA, Rac1 and Cdc42. The latter phosphorylates 
PAK, which activates LIMK to dephosphorylate cofilin, stopping it from disassembling actin 




1.5.3 Pathophysiology  
It has been proposed that synaptic function is affected early in the progression of 
Alzheimer’s disease (Hardy & Selkoe, 2002). This hypothesis is supported by 
studies using animal models of AD and brain tissue samples from AD patients. In 
a mouse model of Alzheimer’s disease, the number of spines has been found to 
be reduced in early stages (Spires et al., 2005). Further evidence comes from 
studies of tissue samples from AD and MCI patients, showing signs of damaged 
neurites, reduced dendritic complexity, and loss of dendritic spines in the 
hippocampus and cortex (Cochran et al., 2014; DeKosky & Scheff, 1990; Penzes 
et al., 2011). Moreover, there is positive correlation between synapse loss and 
decreased cognitive ability (Terry et al., 1991). Therefore, fewer synapses and 
connections may impair information processing because dendritic spines are main 
sites where excitatory synapses form. 
Mounting evidence points to the role of actin cytoskeletal dynamics in dendritic 
spine loss in Alzheimer’s disease. F-actin levels, number and size of spines, and 
inactive cofilin levels are all factors which are reduced both in mouse models of 
AD and in post-mortem samples of cortical tissue of Mild Cognitive Impairment 
and AD (Kommaddi et al., 2018). These results suggest that loss of F-actin may 
be caused by reduced inactive cofilin, leading to dendritic spine loss. One potential 
mediator of dendritic spine structural deficits could be PAK proteins, as deficits 
have been found in Alzheimer’s disease pathology. PAK1 and PAK3 levels in the 
hippocampus, and phosphorylated PAK in the temporal cortex, were found to be 
reduced in post-mortem brain samples from patients with Alzheimer’s disease 
compared to controls (Zhao et al., 2006). In the same study, PAK deficits were 
found in a transgenic mouse model of Alzheimer’s disease; these deficits were 
found to be induced by amyloid-β and reversed by transfecting neurons with active 
wild-type PAK. Furthermore, PAK activity inhibition led to increased cofilin activity 
and memory deficits in adult mice (Zhao et al., 2006). These findings suggest that 




In the case of DLB, it has been hypothesised that α-synuclein aggregates located 
near dendrites and spines may alter dendritic spine dynamics (Froula et al., 2018). 
Several studies provide evidence suggesting that α-synuclein aggregates 
decrease the levels of presynaptic and postsynaptic marker proteins (Kramer & 
Schulz-Schaeffer, 2007), and cause dendritic spine loss (Froula et al., 2018; 
Kramer & Schulz-Schaeffer, 2007). Furthermore, accumulation of α-synuclein 
aggregates in the somatosensory cortex not only triggers the progressive loss of 
dendritic spines, but it also alters spine dynamics such as spine turnover and 
stabilisation in transgenic mice overexpressing α-synuclein (Blumenstock et al., 
2017). These structural consequences may be explained by the alteration of the 
actin cytoskeleton mediated by α-synuclein aggregates. Supporting evidence for 
this hypothesis comes from the findings that abnormal actin-rich inclusions which 
also contained cofilin were found in animal models of α-synucleinopathy and in 
samples from α-synucleinopathy patients (Ordonez et al., 2018). Therefore, DLB 
resembles AD given that synaptic dysfunction and synapse loss occur before 
neurodegeneration and cognitive decline. However, the detailed mechanisms 
underlying the pathophysiology of these neurodegenerative diseases remain 
undefined.  
1.6 Aims and objectives 
As previously mentioned, synaptic plasticity alterations are thought to be the first 
events in the progression of neurodegenerative disorders. The impairments also 
include the reduction in spine density.  
There is evidence linking synaptic plasticity with synaptic remodelling. In addition, 
PAKs are proteins that mediate changes in the actin dynamics that regulate 
synapse remodelling and they may also have a role in long-term synaptic plasticity 
such as LTP.  
The present study was designed to determine the consequences to neuronal 
function of exposure to protein aggregates and determine potential underlying 





The specific objectives are to: 
1. Characterise the contribution of the oligomeric forms of Aβ and α-synuclein to 
LTP impairment.   
2. Characterise the role of Group I PAKs in synaptic plasticity under non-
pathological conditions.   
3. Characterise the components on which Group I PAKs may act in order to 
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Chapter 2 - Materials and Methods 
2.1 Animals 
All procedures involving animals were carried out in accordance with the UK 
Animals (Scientific Procedures) Act, 1986. Acute hippocampal slices were 
obtained from postnatal day (P) 24 to 35 male Wistar rats (Sprague Dawley strain, 
Charles River, UK). These animals were housed in groups and exposed to 12 
hours light / 12 hours dark cycle. Animals were housed in controlled environmental 
conditions with food and water available ad libitum. Hippocampal and cortical 
neurons for cell culture were obtained from P0-3 Wistar rats. 
2.2 Slice preparation 
Animals were sacrificed by cervical dislocation and then decapitated. The skull 
was cut along the longitudinal fissure, as well as on both sides from the midline to 
the orbit. Then both sides of the skull were separated so the brain was rapidly 
removed and placed in ice-cold artificial cerebrospinal fluid (aCSF) containing (in 
mM): NaCl 124, KCl 3, NaHCO3 26, NaH2PO4 1.25, CaCl2 2, MgSO4 1 and d-
glucose 10 (bubbled with 95% O2/5% CO2). The brain was cut to separate the 
hemispheres, one of these was put back into ice-cold aCSF while the other was 
set on a filter paper medial side up. The cerebellum was folded towards the medial 
side using forceps and the cortex was gently pushed away from the transverse 
sinus using a spatula to reveal the hippocampus. The hippocampus was 
separated from the adjoining cortex, then lifted and turned 180° with a curved 
spatula; the remaining cortical tissue still attached to the hippocampus was 
removed. The hippocampus was placed on filter paper and set on a McIllwain 
tissue chopper (Mickle Laboratory Engineering Co. Ltd., Gomshall, UK) to cut 
transverse hippocampal slices (400 µm thick). These slices were placed in ice-
cold aCSF to separate them. Finally, hippocampal slices were stored in a chamber 






2.3.1 Recording equipment set-up 
The recording chamber consisted of a polycarbonate recording chamber (RC-
26G, Warner Instruments) with a glass coverslip base (22 x 40 mm, 64-0707, 
Warner Instruments, CT, USA). Leakage from the chamber was prevented by 
applying vacuum grease to the edges of the chamber before placing it on top of 
the glass coverslip. The chamber was then placed on an anodized aluminium 
platform (P-1, 64-0277, Warner Instruments, CT, USA), which in turn was mounted 
on the platform of an upright FN-S2N microscope (Nikon Instruments Inc., Japan). 
Prior to recording, a hippocampal slice was placed in the recording chamber. As 
the chamber was continuously perfused with aCSF and the flow (2-3 ml/min) 
caused movement, the slice was stabilised by placing on top of it a nylon mesh 
net held by a horseshoe-shaped wire made in-house. A peristaltic pump (Sci-Q 
323; Watson-Marlow Ltd., Falmouth, UK) was used to deliver aCSF saturated with 
95% O2/5% CO2 kept in a water bath at approximately 37°C (Clifton NE1-4, 
Nickel-Electro Ltd., Weston-Super-Mare, UK) to the chamber. The pump was 
connected to polyethylene tubing (2.42 mm outer diameter, 1.67 inner diameter; 
Smiths Medical, London, UK) and Tygon Norprene tubing (4.8 mm outer diameter, 
1.6 mm internal diameter; Harvard Apparatus, Kent, UK). The aCSF was 
preheated using a TC-10 temperature control system (npi electronic GmbH, 
Tamm, Germany) connected to a heated perfusion tube system (HPT, ALA 
Scientific Instruments, Inc., USA) before flowing into the recording chamber to 
maintain a temperature of 29 ± 2°C. Excess aCSF in the chamber was removed 
by suction through a needle connected to a Dymax 30 vacuum pump (Charles 
Austen Pumps Ltd., Surrey, UK). Vibrations during recording were minimized by 
fixing the microscope to an air table (IsoStationTM, Newport, UK). An air 
compressor (JunAir 3-4, 11090, MI, USA) was used to fill the air table with 
compressed air. Interference caused by external electrical fields was prevented 






Recording electrodes were made using borosilicate glass capillaries (Standard 
wall, 1.5 mm outer diameter, 0.86 outer diameter, 100 mm long; Harvard 
Apparatus, Kent, UK). These capillaries were pulled with a P-100 Flaming/Brown 
micropipette puller (Sutter Instruments Co., CA, USA) to achieve a resistance of 
5-7 MΩ, then they were filled with NaCl 3M before attaching them to an electrode 
holder (QSW-T15P, Warner Instruments, CT, USA) which was connected to a 
headstage (CV-203BU, Molecular Devices, CA, USA). The headstage was 
connected to a silver wire (99.9% purity, 0.20 mm diameter, Advent Research 
Materials Ltd., Oxford, UK) coated with silver chloride (AgCl) which allowed the 
transduction of ionic current from the internal solution to electron flow along the 
wire. The headstage was also connected to a second AgCl-coated silver wire; this 
second wire was submerged in the recording chamber to provide a ground 
reference. The position of the recording electrode was controlled by an electronic 
PatchStar micromanipulator (Scientifica, Uckfield, UK). The silver wires were re-
chlorided approximately once every two weeks first by scraping the surface with a 
razor, then immersing them in a NaCl (1M) solution and applying an electrical 
current using a 9V battery for 5 minutes. The silver wires in the recording electrode 
and in the chamber were coated with AgCl only up to the point where they were 
in contact with the filling solution or aCSF, respectively.                                         
Bipolar stimulating electrodes were made by tightly twisting nickel/chromium wires 
(80% Ni, 20% Cr, 0.050 mm diameter; Advent Research materials, Oxford, UK) 
and passed through a glass capillary (prepared as previously described). The 
stimulating electrodes were placed on a mechanical micromanipulator (Narashige 
International Ltd., Japan) for controlling their position on the hippocampus slice. 
These electrodes were connected to stimulating boxes (DS2A-Mk.II, Digitimer 
Ltd., Welwyn Garden City, UK), which delivered 5V monopolar 0.1 ms square-





2.3.3 Extracellular field recording 
Acute hippocampal slices were used to record field extracellular postsynaptic 
potentials (fEPSPs). These potentials were recorded in the CA1 stratum radiatum 
(Figure 2.1) area of the hippocampus using a recording electrode back-filled with 
NaCl (3M) solution. Bipolar stimulation electrodes were used to evoke responses; 
the regions where the stimulating electrodes were placed were the Schaffer 
collateral-commissural pathway and the subiculum, where responses from the 
latter position were used as the non-tetanised control input.  
A stimulus was delivered to each pathway every 30 seconds (0.033 Hz); the 
second pathway was stimulated 15 seconds after the first one, then the stimuli 
continued to be delivered alternately. The slope and peak amplitude (pkAmp) 
measurements of the evoked response were used to determine synaptic efficacy 
(Figure 2.2). The slope is the value of the rate of change of the voltage (mV/ms) 
and it was determined by setting start time and end time following stimulation. 
These time values were set so that the slope was between 20-80% of the peak 
fEPSP amplitude. The pkAmp is the difference between the peak of the response 
and the value of the DC baseline. The stimulation intensity was in the 5-15 V 
range; once a maximum response was reached, the intensity was lowered 
approximately 30% to prevent progressive rundown of responses by 
overstimulation. Each slope datapoint consisted of the average of 4 successive 
responses.  
For LTP experiments, a baseline consisted of stable responses recorded for 30 
minutes before any experimental manipulations. Following this, high-frequency 
stimulation (HFS) was used to induce LTP, which consisted of 2 trains of 100 
pulses at 100 Hz delivered with a 30 s interval. After LTP induction, recording 
continued for 60 to 120 minutes. The slope values were normalised by expressing 
values as a percentage of the average of the responses obtained during the 30-
minute baseline. Data from the same experimental condition were pooled together 
and data points were plotted as the mean ± standard error of the mean (SEM). 




unpaired t-tests based on the values of 5 data points before the end of the 
experiment, where a p-value of 0.05 was considered statistically significant. 
Representative traces are examples of the responses recorded at time points 
indicated by numbers above and below the data shown in graphs. These traces 
consisted of the average of 4 responses. 
For paired-pulse ratio (PPR) experiments, slopes were measured for two stimuli 
using 50, 200, 500 and 1000 ms interpulse intervals. These pairs of stimuli were 
delivered every 30 s, and the responses for each pair were the average of 4 
responses. The PPR results were obtained by dividing the slope of the second 
stimulus by the slope of the first (S2/S1 ratio) and the values from each 
experimental condition were plotted as the mean ± SEM. For analysis of input-
output responses, the fibre volley amplitude and slope were measured at stimulus 
intensities of 2, 4, 8, 10, 15 and 20 mV. Data points were represented as the mean 
± SEM of the data points from all the slices tested in each experimental condition. 
Experiments in which changes in the fibre volley occurred were discarded. 
 
2.3.4 Data acquisition 
The headstage was connected to an amplifier (Axopatch 200B; Axon Instruments, 
Foster City, CA) with the low-pass filter set to 5 kHz. For storage and analysis of 
measurements, signals were converted from analogue to digital by connecting the 
amplifier to a BNC-2110 board (National Instruments, Austin, TX), which in turn 
was connected to a computer with an M-series data acquisition device board 
(National Instruments, Austin, TX). Each sweep consisted of 500 voltage 
measurements in 50 ms intervals. The LTP114J software was used to monitor 
recordings, set recording parameters and capture data online and to reanalyse 






Figure 2.1 Acute hippocampal slice. Top: Photograph of a hippocampal slice; S1 and S2 
indicate the positions of the stimulating electrodes and Rec indicates the position of the 
recording electrode. Bottom: schematic diagram showing the position of the stimulating and 
recording electrodes; S1 placed at the Schaffer collateral pathway (SC), S2 placed at the 













Figure 2.2 Schematic diagram of a typical fEPSP trace. The parameters of 
fEPSPs are indicated on the figure: the stimulus artifact, the fiber volley, the slope 




2.4 Amyloid-β preparation 
HFIP (100% 1,1,1,3,3,3-hexafluoro-2-propanol; Sigma-Aldrich, 99.8% ACS 
reagent grade) was used to dissolve amyloid-β (Aβ) 42 peptide (Millipore, UK) at 
a concentration of 1mg/ml. This solution was incubated for 1 hour at room 
temperature with vortexing at moderate speed every 10 minutes. Then, the 
solution was sonicated for 10 minutes in a water bath sonicator; this was followed 
by drying under a gentle stream of nitrogen gas until the solution evaporated. The 
peptide was resuspended in DMSO (100%) and placed in a rotator for 12 minutes 
at room temperature with vortexing at moderate speed every 3 minutes. The 
resuspended solution was aliquoted into volumes of 10 µl and stored at -80°C. To 
induce Aβ peptide aggregation, D-PBS (Invitrogen, UK) was added to the 
aliquoted solution for a final concentration of 100 µM and this was incubated for 2 
hours at room temperature in a rotator. The aggregated peptide was stored at -
80°C after use. 
 
2.5 α-synuclein preparation 
The α-synuclein (α-syn) samples were obtained by collaboration with Cambridge 
University. These samples consisted of α-synuclein diluted in a Tris 25 mM and 
NaCl 100 mM buffer. The samples were diluted further to 70 µM using the same 
Tris/NaCl buffer, then the solution was aliquoted into smaller volumes and stored 
at -80°C. This solution was diluted in aCSF to a working concentration of 1 µM for 
experiments which involved incubation of acute hippocampal slices with α-syn 
monomers. To induce α-syn peptide aggregation, the solution was incubated in a 
rotating incubator at 37°C, 200 rpm for 12, 13 or 15 hours depending on the 





2.6 Slice incubation and drug application 
For slice incubation, drugs were added to aCFS in 35 mm plates. The aCSF was 
saturated with 95% O2/5% CO2 while the slices were left for different periods of 
time, depending on the experimental condition; incubation times are indicated in 
each figure description. In other cases, drugs were first diluted directly in aCSF 
which was delivered directly to the recording chamber during electrophysiological 
experiments; the specific drug used and time period of drug perfusion are 
indicated on each figure. Table 1 provides a summary of the pharmacological 
agents used, mode of action, suppliers, concentrations and solvents. Drug 































50 µM ddH2O 
IPA-3 
Group I PAK 
inhibitor 
Abcam 25 µM DMSO 
FRAX486 





























5 µM ddH2O 
Table 2.1 Drugs used. 
 
2.7 Cell culture 
Hippocampal and cortical neurons were cultured based on an existing method 
(Brewer and Torricelli, 2007). Animals were sacrificed by cervical dislocation. The 
brain was transferred to HABG medium (HibernateA, ThermoFisher #A1247501; 
B-27 Supplement, ThermoFisher #17504044; and Glutamax, ThermoFisher 
#35050038). The cerebellum and brainstem were removed, while the cortex and 
hippocampi were isolated from the midbrain and meninges were removed. The 
tissue was pulled apart into pieces of approximately 2 mm3, then digested with 
Trypsin-EDTA (ThermoFisher #25200056) in HibernateA and Glutamax for 15 
minutes at 37°C. Trypsin was inactivated by addition of HABG, the tissue was 
further dissociated by pipetting tissue into and out of Pasteur pipettes with a flame 
polished tip. The neurons were isolated using OptiPrep Density Gradient Medium 
(Sigma-Aldrich #D1556) in HABG and quantified using Typhan-blue exclusion in 
a haemocytometer. The neurons were transferred to Neurobasal/B27 
(Neurobasal-A medium, ThermoFisher #10888022, Gentamycin, ThermoFisher 
#15710049, B-27 Supplement and Glutamax). Neurons were plated onto 13-mm-
diameter glass coverslips coated with poly-D-lysine (Sigma-Aldrich #P7280) at a 
density of 3 x 104 cells per square centimetre. Neurons were incubated at 20% 





2.8 Calcium Imaging 
The chemical calcium indicator Fluo4-AM (Life technologies F14201) was used to 
detect changes in intracellular calcium in primary cultured hippocampal neurons 
(DIV 14-29) cultured on 13 mm coverslips. Fluo4-AM stock solution was prepared 
by dissolving 50 µg of Fluo4-AM in 9.1 µl of DMSO, to a concentration of 5 mM. 
Neurons were washed 3 times with 0.1% BSA in HEPES Buffered Saline (HBS) 
containing (in mM): 119 NaCl, 5 KCl, 25 HEPES, 33 glucose, 2 CaCl2, 2 MgCl2, 
0.001 glycine, 0.1 picrotoxin (pH 7.4) supplemented with BSA (1 mg/ml).  
Neurons on coverslips were loaded with 5 µM Fluo4-AM diluted in HBS/BSA for 1 
hour in an incubator at 20% O2, 5% CO2, 37°C in the dark. Subsequent to this, 
neurons were washed 3 times with HBS before placing them in the recording 
chamber, then they were perfused with HBS throughout the whole experiment at 
a flow rate of approximately 2ml/min. Fluo4 AM fluorescence was recorded for 25 
minutes in total, an image was taken every 30 seconds. Cell imaging was 
performed using a Leica DM IRBE (Wetzlar, Germany) inverted microscope with 
a motorised stage (Optiscan II, Prior Scientific, Cambridge, UK) and a digital 
camera (ORCA 100 C4742-95, Hamamatsu Photonics, Hamamatsu, Japan) with 
a charge-couple device. All images were taken with a 20x objective. Images were 
captured using SimplePCI imaging software (Hamamatsu Photonics, K. K, 2017). 
A baseline of 10 minutes was recorded before adding DMSO alone or 500nM 
FRAX-486 diluted in DMSO for 10 minutes. KCl causes resting membrane 
potential depolarization which results in calcium influx into the neuron, therefore, 
it was added 5 minutes before the end of each experiment to identify neurons 
which showed increased fluorescence.  
Icy software (Institut Pasteur, 2011) was used for image analysis. The total 
fluorescence intensity was obtained by selecting regions of interest (ROIs) on the 
somatic area of each neuron. Fluorescence intensity values were obtained for 
each ROI. Fluorescence was measured as the ratio of the fluorescence intensity 
as the experiment is running and the fluorescence intensity at the start of the 




fluorescence. This measure relative to the initial signal is used as a way of 
normalising indicator concentration differences between neurons (Bootman et al., 
2013). Pooled data from experiments were normalised to the average of values 
obtained during the baseline and were expressed as a percentage.  
2.9 Chemical LTP  
The coverslips used for these experiments were observed under the microscope 
to inspect neuronal morphology characteristics, such as the presence of viable 
cell bodies and neurites, before continuing with experiments. For glycine 
stimulation, hippocampal cultured neurons (DIV14-21) were incubated for 3 
minutes in a Mg2+-free bathing solution containing (mM): 150 NaCl, 5 KCl, 2 CaCl2, 
10 HEPES, 30 glucose, 0.001 strychnine, 0.02 bicuculline methiodide with 
(experimental group) or without (control group) 0.2 glycine (Sigma Aldrich) and 
0.001 picrotoxin (Fortin et al., 2010; Groc et al., 2008). Following the 3 minutes 
incubation, neurons were kept in bathing solution without glycine for 15 minutes 
before fixing and staining them.  
The application of glycine enhances NMDAR activation, picrotoxin and biccuculine 
are GABAA receptor antagonists which block inhibitory synapses, strychnine 
blocks glycine receptors and the absence of Mg2+ reduces NMDAR pore blocking 
(M. Patterson & Yasuda, 2011). The bath application of the solution with glycine 
strongly stimulates most synapses, triggering the synchronisation of nearby 
neurons and producing long-term strengthening of excitatory synapses (Molnár, 
2011). 
To test whether this chemical LTP stimulation depends on NMDAR, neurons were 
incubated with antagonists, such as MK-801 or AP5, diluted in culture medium for 
30 minutes prior to stimulation. Other sets of neurons were incubated for ~1.5 - 2 
hours with a group I PAK inhibitor, IPA-3 (25 µM) or FRAX486 (500 nM), diluted 
in the culture medium prior to chemical LTP stimulation. Neurons were left in an 





2.10 Phalloidin staining and quantification of spine density and morphology 
Hippocampal neurons were fixed with 4% paraformaldehyde in PBS for 15 
minutes at room temperature. Neurons were washed three times in PBS and 
permeabilized in PBS containing 0.3% Triton for 15 minutes. After washing three 
times in PBS, neurons were stained with Alexa Fluor 568- phalloidin (Invitrogen) 
diluted with PBS at 1:40 to stain actin and visualize dendritic spines. Coverslips 
were washed and mounted onto slides using Hard-set Vectashield with DAPI. 
Fluorescent images were obtained using a Leica DFC7000T camera attached to 
a Leica DM2000 microscope with a 100x oil-immersion lens. The labels for all 
microscope slides were concealed from the experimenter until all images were 
taken and data was analysed. Spines were defined as visible protrusions 
extending from dendrites. From each neuron, up to 3 10 µm2 sections of primary 
and secondary dendrites were analysed. Spine area, circularity, and spine number 
measurements were assessed using National Institutes of Health Image J 
software. 
 
2.11 Immunodetection of surface GluA2-AMPARs 
Following the chemical LTP protocol described above, surface GluA2-AMPARs 
were incubated for 15 minutes with an anti-GluA2 subunit mouse monoclonal 
antibody (1:100; Thermo Fisher Scientific) diluted in PBS containing 3% BSA. 
Hippocampal neurons were washed with PBS and fixed with 4% 
paraformaldehyde in PBS for 15 minutes at room temperature. To add a 
postsynaptic location marker, neurons were washed 3 times in PBS and 
permeabilised in PBS containing 0.3% Triton X-100 for 15 minutes. Neurons were 
then washed and blocked with PBS containing 5% BSA for 60 minutes, followed 
by incubation with an anti-Shank3 rabbit monoclonal antibody (1:400; Cell 
Signalling Technology) diluted in PBS containing 3% BSA. After washing 3 times 




Fluor 555 (1:50; Thermo Fisher Scientific) and goat anti-rabbit IgG secondary 
antibody Alexa Fluor 488 (1:50; Thermo Fisher Scientific) diluted in PBS 
containing 3% BSA for 60 minutes. Coverslips were washed and mounted onto 
slides using Hard-set Vectashield with DAPI (Vector laboratories) and kept at 4°C 
until quantification.  
Confocal images were obtained using a Leica SP5-AOBS confocal laser scanning 
microscope with a 63x 1.4 oil-immersion objective. Images of dendrites were 
digitally zoomed-in to reach a maximum resolution of approximately 70 nm. These 
images were taken as z projections with step intervals of 0.25 µm. The stacks 
contained 12-15 planes which encompassed a dendritic section from top to 
bottom.  To measure changes in surface GluA2 in postsynaptic sites following 
chemical LTP, Shank staining was used as a mask filter to detect postsynaptic 
GluA2 staining. Then GluA2 integrated fluorescence levels within Shank clusters 
were measured. Two to 3 20 µm-long sections of primary and secondary dendrites 
from each neuron were analysed. The specific number of coverslips and neurons 
quantified for each experiment is stated within the corresponding figure 
description. Each experimental condition using the chemical LTP protocol was 
repeated at least 3 times with independent neuronal culture preparations. 
Fluorescence measurements were obtained using the National Institutes of Health 
Image J software (Abràmoff et al., 2004). 
 
2.12 Statistical analyses 
Data were analysed from hippocampal slices or neurons; numbers of slices, 
animals, neurons or coverslips are specified in each figure. Data pooled across 
slices or neurons are expressed as the mean ± SEM. For electrophysiology 





Statistical significance was considered at p-values lesser than 0.05. For LTP and 
calcium imaging experiments, statistical significance was tested using unpaired 
two-tailed t-tests. Two-way ANOVA was used for assessing statistical differences 
in input-output responses and PPR, while Kolmogorov-Smirnov was used for 
comparing differences on surface GluA2 staining between control and chemical 
LTP stimulation. Graphs were generated using a range of libraries in python, and 
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Chapter 3 - The effects of oligomerised protein on synaptic function 
3.1 Introduction 
3.1.1 Aberrant protein aggregates and dysregulation of synaptic function 
The aberrant aggregation of proteins is a hallmark feature of many 
neuropathological diseases. Insoluble and diffusible oligomers composed of 
different proteins can be found in diseases that are clinically, genetically and 
pathologically distinct. For example, Aβ accumulates extracellularly and 
hyperphosphorylated tau accumulates intracellularly in Alzheimer’s disease (AD); 
the accumulation of these aberrant proteins can be first seen in the hippocampus, 
and they spread to cortical areas with disease progression. In the case of 
Parkinson’s disease (PD), PD dementia and dementia with Lewy Bodies (DLB), 
α-synuclein accumulates intracellularly in cell bodies and axons starting from the 
substantia nigra in the brainstem to then spread into the midbrain and cortical 
regions. Misfolded protease-resistant prion proteins accumulate intracellularly in 
Creutzfeldt-Jakob disease in various cortical areas. TDP-43 accumulates in 
amyotrophic lateral sclerosis which affects motor neurons and frontotemporal 
lobar dementia which affects the frontal and temporal lobes. Also, Huntingtin is a 
polyglutamine protein which accumulates intracellularly and primarily affects the 
striatum and cortex in Huntington’s disease. However, though the specific 
mechanisms that underpin the development of pathology in these diseases differ, 
the ultimate consequences of the deposition of aggregated protein appear to be 
similar: neuronal impairment and synaptic dysfunction.  
With the aim of elucidating how pathological protein aggregation leads to cognitive 
impairment, many studies have turned to in vitro models of disease and examined 
the consequences on synaptic plasticity. Many studies have shown that the 
application of Aβ (Klyubin et al., 2008; Shankar et al., 2007; Townsend et al., 2006; 
Walsh et al., 2002), α-synuclein (Diógenes et al., 2012), prion protein (Johnston 
et al., 1998), tau (Ondrejcak et al., 2018), or Huntingtin (Quirion & Parsons, 2019; 




there is an ultimately shared mechanism across these diverse proteins which 
mediates this effect on the synapse, however, is unknown. 
One potential consistent feature of these different proteins and their shared effect 
on synaptic plasticity is their aggregation status. Here, the extent of aggregation 
(or oligomerisation) is thought to determine the synaptotoxicity of the protein. 
Soluble Aβ oligomers inhibit LTP in hippocampal slices whereas insoluble amyloid 
plaques nor Aβ monomers do not (Shankar et al., 2008). Microinjection of medium 
containing Aβ oligomers and monomers inhibited LTP in vivo, but this effect was 
mediated by oligomers not monomers (Walsh et al., 2002). Another study found 
that Aβ monomers did not affect LTP, whereas trimers were more effective at 
inhibiting LTP than dimers and tetramers, which had an intermediate effect 
(Townsend et al., 2006). In turn, the anti-Aβ antibody reverses the effect of Aβ 
oligomers on LTP (Klyubin et al., 2008; Townsend et al., 2006). 
The aggregation status of α-synuclein is thought to be the mechanism that leads 
to PD. A study by Winner et al. found that α-synuclein oligomerisation led to 
enhanced toxicity in the rat substantia nigra (Winner et al., 2011). Similar to Aβ, 
incubating rat hippocampal slices with α-synuclein oligomers but not monomers 
or fibrils resulted in inhibition of LTP induced by theta-burst stimulation (Diógenes 
et al., 2012). In another study, three types of α-synuclein oligomers co-localised 
with excitatory synapses and reduced LTP in mice hippocampal slice (van 
Diggelen et al., 2019). Moreover, LTP is impaired in striatal cholinergic 
interneurons of transgenic animals overexpressing wild type human α-synuclein 
and truncated α-synuclein (Tozzi et al., 2016). In the latter study, the findings were 
replicated by applying exogenous α-synuclein oligomers where LTP was 
adversely affected in a dose-dependent manner.  
In terms of other types of aggregates, previous research has established that 
injection of abnormal prion proteins from brain homogenates of scrapie-infected 
mice leads to impairment in LTP stabilisation and maintenance in hippocampal 




Regarding huntingtin, studies have shown that LTP is impaired in transgenic mice 
expressing mutant huntingtin compared to wild-type animals (Quirion & Parsons, 
2019; Usdin et al., 1999). The LTP impairment seen in the latter studies may be 
explained by the ability of mutant huntingtin to form oligomers (Stott et al., 1995). 
In addition, many recent studies suggest that application of exogenous soluble 
aggregates of wild type tau or human recombinant tau inhibited LTP while tau 
monomers and fibrils did not (Ondrejcak et al., 2018).   
Together then, these studies indicate that a consistent factor across these 
divergent protein types, to determine the extent of their toxicity, is their level or 
type of aggregation. The consequences of specific protein aggregate isoforms for 
neuronal function, however, remain relatively poorly characterised. 
 
3.1.2 Concentration threshold of aggregate-mediated pathogenesis 
The link between the aggregation profile and synaptic impairment is currently 
unknown. One possible explanation could be the available concentration of toxic 
protein. In the case of Aβ, it has been reported that low concentrations 
(approximately 100 - 300 pM) of soluble Aβ low-n oligomers such as dimers, 
trimers and tetramers were found to robustly inhibit LTP (Townsend et al., 2006). 
However, studies have found that there is a concentration-dependent aspect of 
Aβ-induced synaptic depression as increasing the concentration from 1 µM Aβ40  
and 50 nM Aβ42  to 10 µM Aβ40 and 500 nM Aβ42 led to LTP impairment 
(Kamenetz et al., 2003). In addition, exposing hippocampal slices to Aβ oligomers 
from cortical samples of AD patients adversely affected LTP in a dose-response 
manner (Shankar et al., 2008). It is important to note that the Aβ42 peptide is more 
prone to aggregate (Chen & Glabe, 2006; Marina et al., 2003) and genetic 
conditions in which mutations result in increased production of Aβ lead to early-
onset familial AD (Citron et al., 1992; Rovelet-Lecrux et al., 2006).  
With respect to α-synuclein, a study testing three types of α-synuclein, oligomers 




and at 100 nM for unmodified α-synuclein (Diggelen et al., 2019). In contrast,  
incubating slices with α-synuclein oligomers at concentrations of 10-50 nM did not 
affect LTP, but incubating slices with α-synuclein oligomers at a concentration of 
500 nM resulted in LTP impairment as the responses returned to baseline levels 
60 minutes after induction (Diógenes et al., 2012).  
 
3.1.3 Mechanisms of synaptic dysfunction induced by protein aggregates 
Although the mechanisms by which protein aggregation contribute to 
neurodegeneration are still unknown, one potential mechanism may be that 
aggregates cause abnormal membrane permeabilization. Data from several 
studies suggest that Aβ and α-synuclein form “ring-like” oligomeric structures 
which form pores on the surface of membranes (Lashuel et al., 2003; Rochet et 
al., 2004; Volles & Peter T. Lansbury, 2002). The toxic effects of these “ring-like” 
structures led to dysregulated influx of ions, thereby affecting neuronal signal 
transmission (Furukawa et al., 2006). Furthermore, another study revealed that 
the interaction between Aβ and α-synuclein led to the formation of “ring-like” 
structures that form ion-channels, and that cells expressing α-synuclein and 
treated with Aβ showed altered synaptic dysfunction due to increased calcium 
influx (Tsigelny et al., 2008). 
Alternatively, data from several studies suggest that protein aggregates disrupt 
the number and function of synaptic receptors. Several reports have shown that 
increased production of Aβ in cultured hippocampal neurons or hippocampal 
organotypic slices resulted in reduced synaptic surface AMPAR and NMDARs 
(Almeida et al., 2005; Hsieh et al., 2006a; Snyder et al., 2005). This effect might 
be mediated by oligomeric Aβ as it was found that exposure of neurons to Aβ 
oligomers resulted in decreased surface expression of NMDARs (Lacor et al., 
2007). In terms of synaptic activity, studies have shown that Aβ production in 
neuronal slices overexpressing APP weakens glutamatergic synaptic 




Various studies have assessed the effect of oligomers on neuronal connectivity 
and plasticity. In mammalian brains, most excitatory connections are formed on 
small protuberances along dendrites termed dendritic spines. Dendritic spines are 
dynamic structures which undergo changes in number and morphology to 
establish or remodel neuronal circuit connectivity (Penzes, Cahill, Jones, 
Vanleeuwen, & Woolfrey, 2011). Indeed, increased levels of Aβ due to APP 
overexpression in hippocampal organotypic slices, as well as incubation of slices 
with Aβ for 7 days, reduce dendritic spine density (Hsieh et al., 2006a). It has also 
been reported that mature cultured hippocampal neurons exposed to Aβ 
oligomers (500 nM) for 24 hours result in disruption of dendritic spine morphology 
and reduced spine density (Lacor et al., 2007). In another study, neurons in 
organotypic hippocampal slices incubated with low-n number Aβ oligomers 
(approximately 100-300 pM) for 5 to 15 days showed significantly reduced spine 
density (Shankar et al., 2007a).  
It has also been suggested that dysregulation of synaptic plasticity caused by 
small oligomers is an initial and contributing factor to progressive 
neurodegeneration (Selkoe, 2002). A considerable amount of research has shown 
that Aβ oligomers impair LTP  in vivo and in vitro (Billings, Oddo, Green, McGaugh, 
& LaFerla, 2005; Chapman et al., 1999; Cleary et al., 2005; Cullen, Suh, Anwyl, & 
Rowan, 1997; Freir, Holscher, & Herron, 2001; Walsh et al., 2002b). 
Notwithstanding the extensive progress that has been made, the neurobiological 
basis of how protein aggregates disrupt synaptic plasticity needs to be elucidated. 
 
3.2 Aims and Hypotheses 
The aim of this chapter is to analyse the effects of α-synuclein aggregation on 






3.3.1 Time-dependent effect of protein aggregation and synaptotoxicity 
As previously outlined, the aggregation status – and what synaptotoxicity this 
confers – is well established in the case of Aβ (Hsieh et al., 2006; Shankar et al., 
2007, 2008; Townsend et al., 2006; Walsh et al., 2002). However, comparatively 
little is known about the relationship between aggregate and synapse dysfunction 
for other pathogenic proteins. In order to substantiate the hypothesis that it is 
protein aggregation per se that drives the synapse impairment (rather than a 
particular facet of the protein in question itself), it would need to be shown that, as 
with Aβ, there are aggregation status-dependent effects with other proteins. We 
decided to focus on the alpha-synuclein protein, the role of which in synaptic 
dysregulation is comparatively less well studied. 
Synthetic α-synuclein was obtained from a collaborator (Klennerman Group, 
University of Cambridge). When initially derived, α-synuclein is in a monomeric 
form. However, following solubilisation in a Tris (25 mM)/NaCl (100 mM) solution, 
and incubation at 37 °C (as explained earlier in section 2.5), the protein forms 
aggregates. Interestingly, there is a time-dependence to this effect, where large 
n-aggregates form over time (Klennerman Group, personal communication).  
We began by preparing 3 distinct α-synuclein preparations, which had been 
aggregated for 3 different time periods (12h, 13h and 15h). We then treated 
hippocampal slices with 1 µM of these preparations for 2-2.5h and examined the 
consequences on acute hippocampal slice synaptic plasticity. This was 
undertaken by means of measuring fEPSPs in area CA1, evoked by stimulation 
of Schaffer-collaterals (see Chapter 2, section 2.3.3). 
When compared with control, untreated slices, we found that application of 12h-
aggregated α-synuclein had no effect on the magnitude of LTP (α-syn 12h: 140 ± 
9% of baseline, n = 3, closed circle; Control: 146 ± 12%, n = 3, open circles, p = 
0.713, Figure 3.1). Similarly, when slices were treated with 13h-aggregated α-




= 3, closed circle; Control: 185 ± 17%, n = 3, open circles, p = 0.430, Figure 3.2). 
In contrast to these results, when slices were treated with 15h-aggregated α-
synuclein, there was a robust inhibition of LTP (α-syn 15h: 122 ± 9% of baseline, 
n = 9, closed circle; Control: 152 ± 7%, n = 9, open circles, p = 0.0218, Figure 
3.3). Taken together, these results indicate a time-dependent aggregation effect 
of α-synuclein on hippocampal LTP and could suggest that the synaptotoxicity of 






Figure 3.1 Application of -synuclein oligomerised for
12h does not affect LTP. Slices incubated with -synuclein
oligomers (1 mM) for 2 - 2.5 hours (control n=3, α-syn n=3,
p-value = 0.713) compared with untreated control.




















































Figure 3.2 LTP can be induced following application of
-synuclein oligomerised for 13h. Slices were incubated
with -synuclein oligomers (1 mM) for 2 - 2.5 hours (control
n=3, α-syn n=3, p-value = 0.430) compared with untreated
control.



















































Figure 3.3 Application of -synuclein oligomerised for
15h inhibits LTP. Slices were incubated with -synuclein
oligomers (1 mM) for 2 - 2.5 hours (n=8) compared with
untreated slices as control (n=9, p-value = 0.0218) .



















































3.3.2 No effect of α-synuclein on tetanus-evoked synaptic transmission 
Our previous experiments have shown that LTP inhibition by α-synuclein 
oligomers was dependent on its aggregation status. Strong depolarisation is 
necessary to activate enough NMDARs to reach a critical level of intracellular Ca2+ 
that ensures LTP stabilisation (Bliss & Collingridge, 1993; Robert C Malenka & 
Nicoll, 1993). Accordingly, our next aim was to determine whether α-synuclein 
oligomers affected the induction of LTP by decreasing the level of depolarisation 
induced by tetanic stimulation. To test this hypothesis, we assessed synaptic 
efficacy as the cumulative amplitude of fEPSPs evoked by each of the 2 trains of 
100 pulses delivered at 100 Hz in slices preincubated with α-synuclein oligomers 
and in control slices using the data from the experiments described in section 
3.3.1. 
When cumulative fEPSP amplitude profiles were compared to control, there were 
no significant differences in slices incubated with α-synuclein oligomerised for 12 
hours in response to tetanus 1 (α-syn 12h: 3349 ± 621% of the first fEPSP, n = 3, 
red; Control: 3856 ± 618%, n = 3, black, p = 0.594, Figure 3.4, left) or tetanus 2 
(α-syn 12h: 1963 ± 227% of the first fEPSP, n = 3, red; Control: 2345 ± 386%, n = 
3, black, p = 0.441, Figure 3.4, right). No significant differences in slices 
incubated with α-synuclein oligomerised for 13 hours in response to tetanus 1 (α-
syn 13h: 2100 ± 114% of the first fEPSP, n = 3, red; Control: 1528 ± 186%, n = 3, 
black, p = 0.059, Figure 3.5, left)  or tetanus 2 (α-syn 13h: 1453 ± 176% of the 
first fEPSP, n = 3, red; Control: 1425 ± 136%, n = 3, black, p = 0.905, Figure 3.5, 
right) were observed either. Finally, there was no significant difference in the 
cumulative fEPSP amplitude profile in α-synuclein oligomerised for 15 hours 
compared to controls in response to tetanus 1 (α-syn 15h: 3619 ± 265% of the first 
fEPSP, n = 9, red; Control: 3561 ± 352%, n = 9, black, p = 0.897, Figure 3.6, left) 
or tetanus 2 (α-syn 15h: 2105 ± 244% of the first fEPSP, n = 8, red; Control: 2440 
± 373%, n = 9, black, p = 0.464, Figure 3.6, right). This combination of findings 
suggests that the inhibitory aggregation effect of α-synuclein on hippocampal LTP 





Figure 3.4 α–syn does not affect the cumulative
depolarisation evoked by tetanic stimulation. The cumulative
pulse amplitude expressed as the fold increase from the first
pulse amplitude in each train of high-frequency stimulation (two
trains of 100 pulses, 100 Hz) in control slices (black symbols) and
in slices incubated for 2-2.5 hours with α–syn oligomerised for 12






Figure 3.5 Oligomerising α–syn for 13h does not affect
the cumulative depolarisation evoked by tetanic
stimulation. The cumulative pulse amplitude expressed as
the fold increase from the first pulse amplitude in each train
of high-frequency stimulation (two trains of 100 pulses, 100
Hz) in control slices (black symbols) and in slices incubated
for 2-2.5 hours with α–syn oligomerised for 13 hours (red






Figure 3.6 α–syn oligomerised for 15h does not affect the
cumulative depolarisation evoked by tetanic stimulation. The
cumulative pulse amplitude expressed as the fold increase from
the first pulse amplitude in each train of high-frequency stimulation
(two trains of 100 pulses, 100 Hz) in control slices (black symbols)
and in slices incubated for 2-2.5 hours with α–syn oligomerised for
15 hours (red symbols). Data from Fig 3.3; all values are





3.3.3 No effect of α-synuclein monomers on hippocampal LTP induction 
Several lines of evidence suggest that oligomeric species of proteinaceous 
aggregates are the drivers of synaptic dysfunction (Hsieh et al., 2006; Shankar et 
al., 2007, 2008; Townsend et al., 2006; Walsh et al., 2002). However, it was 
necessary to confirm whether the synthetic α-synuclein in monomeric form that 
we prepared affected LTP, to control for presence of the protein alone. The 
samples we used for these experiments were solubilised and diluted in Tris 25 
mM and NaCl 100 mM buffer. Afterwards, hippocampal slices were incubated with 
1 µM of monomeric α-synuclein for 2-2.5h before measuring extracellular fEPSPs 
in area CA1, evoked by stimulation of Schaffer-collaterals to assess the effect on 
synaptic plasticity. 
As shown in Figure 3.7, LTP was unaffected by application of monomeric α-
synuclein when compared with untreated slices (α-syn monomer: 140 ± 8% of 
baseline, n = 5, closed circle; Control: 166 ± 13%, n = 5, open circles, p = 0.124). 






Figure 3.7 -synuclein monomers do not affect LTP.
Slices incubated with -synuclein monomers at a
concentration of 1 mM for 2 hours (n = 5) exhibited LTP
similar to control slices (n = 5).




















































3.3.4 No role for GSK-3β in the a-synuclein mediated inhibition of LTP 
Aβ inhibits LTP by a pathway that activates caspase-3, which cleaves Akt1 and 
leads to activation of glycogen synthase kinase-3β (GSK-3β) (Jo et al., 2011). We 
hypothesised that this could underpin a shared mechanism of synaptic 
impairment, and that this pathway would be activated by protein oligomers per se, 
regardless of their specific molecular composition. To test this, we pre-incubated 
hippocampal slices with a GSK-3β inhibitor, CT-99021 (1 µM) for 30 minutes 
before incubating them for 2 - 2.5 hours with α-synuclein oligomers (1 µM) 
oligomerised for 15 hours. As shown in Figure 3.8, CT-99021 did not prevent the 
inhibition of LTP caused by α-synuclein (α-syn: 122 ± 9% of baseline, n = 9, closed 
circle; α-syn + CT-99021: 132 ± 12%, n = 6, open circles, p = 0.522). Therefore, 
this result suggests that α-synuclein may exert its inhibitory effect through a 
mechanism independent of GSK-3β activation. 
To reduce GSK-3β activity slices were exposed to 1 µM CT-99021 30 minutes 
prior to incubation with α-synuclein. However, we did not assess whether the CT-
99021-treated slices exhibited reduced activation of GSK-3β compared to control 
slices. LTP was blocked in both conditions, in slices incubated with α-synuclein 
and in slices incubated with CT-99021 and α-synuclein, therefore there was no 
effect of CT-99021 pre-incubation on LTP inhibition. However, if the degree to 
which CT-99021 inactivated GSK-3β activity was not sufficient, then it remains 
unclear whether LTP is not rescued by GSK-3β inhibition because of GSK-3β was 
still active or because the effect of α-synuclein does not trigger the same 
pathogenic pathway as Aβ.  
GSK-3β is inactivated by phosphorylation at the serine 9 residue (Stambolic & 
Woodgett, 1994). Therefore, to confirm our results further experiments should 
assess GSK-3β activity by determining the protein levels of phosphorylated and 
unphosphorylated GSK-3β via Western Blot comparing slices incubated with CT-






Figure 3.8 LTP inhibition mediated by -synuclein
oligomers is not prevented by CT-99021. Slices were
incubated with a GSK-3β inhibitor, CT-99021, for 30
minutes prior to α–synuclein oligomers (15h) incubation, (n
= 6) compared to slices incubated with α–synuclein
oligomerised for 15h (n = 9) , p = 0.552.


















































3.3.5 Subthreshold concentrations of protein aggregates are additive to inhibit LTP 
It is widely accepted that Aβ soluble oligomers block LTP (Jo et al., 2011; Klyubin 
et al., 2008; Shankar et al., 2008; Townsend et al., 2006; Walsh et al., 2002). 
Interestingly, in our previous experiments detailed above, we found that α-
synuclein oligomers also significantly reduce LTP. Some evidence suggests that 
Aβ and α-synuclein can act synergistically (Bate et al., 2010; Clinton et al., 2010; 
Lashley et al., 2008; Masliah et al., 2001). We therefore wanted to test our 
hypothesis that reaching a threshold of aggregated protein per se was the key 
determinant for synaptic impairment. It has been suggested that synthetic Aβ 
reliably inhibits LTP at a minimum concentration of 500 nM (H.-W. Wang et al., 
2002; Q. Wang et al., 2004). Acute hippocampal slices were therefore pre-
incubated for 2 hours with Aβ and α-synuclein oligomers at lower concentrations 
(250 nM and 50 nM, respectively) than those needed to significantly reduce LTP 
independently. 
LTP was not affected in co-incubated slices when compared with that observed in 
untreated (control) slices (Aβ (250 nM) α-syn (50 nM): 139 ± 26% of baseline, n = 
3, closed circle; Control: 141 ± 8%, n = 4, open circles, p = 0.948, Figure 3.9). 
However, increasing the concentration of α-synuclein up to 250 nM produced LTP 
impairment in slices pre-incubated with Aβ (250 nM) and α-synuclein (250 nM) for 
2 hours (Aβ (250 nM) α-syn (250 nM): 117 ± 9%, n = 6, closed circle; Control: 165 
± 9% of baseline, n = 7, open circles, p = 0.004, Figure 3.10). Taken together, 
these results suggest that when a threshold is reached for the presence of 
oligomerised protein, α-synuclein and Aβ oligomers may act in a cooperative 
fashion to augment toxicity.  
This work suffers from a number of limitations, as the level of aggregation and 
biological activity of Aβ and α-synuclein were not tested. As previously mentioned 
in section 3.3.1, confirming that the Aβ and α-synuclein were aggregated could be 
confirmed in future experiments by western blots (Shankar et al., 2008; Walsh et 
al., 2002); while the biological activity of the protein aggregates could be tested by 







Figure 3.9 Aβ oligomers (250 nM) and α-synuclein
oligomers (50 nM) combined not affect LPT. Slices were
incubated with 250 nM Aβ oligomers + 50 nM α-synuclein
oligomers (n = 3) control (n = 4), p = 0.948.



















































Figure 3.10 Aβ oligomers (250 nM) combined with α-
synuclein oligomers (250 nM) impaired LTP. Slices were 
incubated with 250 nM Aβ (oligomer) + 250 nM α-synuclein 
(oligomer) (n = 6) control (n = 7) p = 0.004. 













































3.4.1 Aggregation status and synaptotoxicity 
Increasing evidence supports the notion that there is overlap between pathological 
characteristics of different neurodegenerative diseases (Baker & Götz, 2015). 
Various studies suggest that the accumulation of protein aggregates is damaging 
to synaptic plasticity. Therefore, our aim was to test whether the presence of 
protein aggregates, other than the typical Aβ oligomers, affected LTP. To test this 
hypothesis, we incubated slices with α-synuclein oligomerised for different periods 
of time then tested whether this affected long-term synaptic plasticity. Our results 
show that only the samples which had been left to oligomerise for 15 hours 
impaired LTP. Consequently, our findings suggest that there might be a 
concentration needed to be surpassed of α-synuclein to produce LTP impairment. 
However, one limitation with this explanation is that we did not assess the sizes of 
α-synuclein oligomer assemblies contained in our samples. In future 
investigations, it will be necessary to identify the specific fragments that inhibit LTP 
and which components of the LTP signalling cascade are involved in this process. 
In this study, incubation of slices with low concentrations of Aβ (250 nM) + α -
synuclein (50 nM) did not impair LTP. However, increasing the concentration to 
Aβ (250 nM) + α -synuclein (250 nM) impaired LTP. These concentrations of both 
α-synuclein or Aβ do not inhibit LTP on their own, but they impair LTP when 
applied together as long as the concentration of α -synuclein was increased to at 
least 250 nM. Our results are consistent with previous studies in which 
concentrations of α-synuclein oligomers ranging from 10 to 50 nM do not produce 
significant changes in LTP, whereas incubation of slices with α-synuclein 
oligomers at a concentration of 500 nM resulted in LTP impairment (Diógenes et 
al., 2012). In another study, a concentration-dependent effect was also shown for 
different species of Aβ oligomers as increasing the dose from 1 μM Aβ40 + 50 nM 
Aβ42 to 10 μM Aβ40 + 500 nM Aβ42 lead to a significant difference on depression 




As previously mentioned, Aβ inhibits LTP through the caspase-3-GSK-3β cascade 
and α-synuclein promotes GSK-3β activation. Although LTP impairment mediated 
by α-synuclein oligomers was not prevented by CT-99021, one possible 
explanation for the mechanism for LTP inhibition in our experiments involving both 
Aβ (250 nM) and α-synuclein (250 nM) might be that activation of GSK-3β by α-
synuclein enhances the effect of the caspase-3-GSK-3β cascade triggered by a 
lower concentration of Aβ. Alternatively, various studies have shown that Aβ and 
α-synuclein adversely affect glutamatergic synaptic transmission (Diógenes et al., 
2012; Kamenetz et al., 2003; Shankar et al., 2007), a natural progression of this 
work is to analyse the effects of these oligomers on postsynaptic receptors that 
mediate LTP. 
It was observed by the Klenerman research group that the aggregation protocol 
produced small fibrils after 24 hours, therefore we chose three different incubation 
periods that were shorter to avoid the production of fibrils. However, one limitation 
of these experiments is that we did not quantify the specific amount of protein 
aggregation for the different incubation periods used. In future work, it may be 
useful to measure the level of aggregation at 12h, 13h and 15h using gel 
electrophoresis for separating the aggregates by molecular weights and Western 
blot for detecting α-synuclein with an anti-α-synuclein primary antibody (Newman 
et al., 2013). We expect that the resulting banding pattern would show higher 
molecular bands for samples incubated for longer periods. However, the absence 
of a band would suggest that α-synuclein is highly aggregated so the protein would 
not be able to run through the gel. Then, the time course of aggregation could be 
monitored using a real-time Thioflavin T (ThT) fluorescence aggregation assay as 
the ThT dye gives a fluorescence signal upon binding to protein aggregates 
(Sulatskaya et al., 2017). 
To confirm whether the α-synuclein samples we used were biologically active, we 
could use methods that assess the effects of aggregates on the integrity of the cell 
membrane by quantifying the release of the cytoplasmic enzyme lactate 




neurons would be incubated with media-alone, α-synuclein oligomerised for 12h, 
13h, and 15h before LDH quantification, as previously demonstrated by (Wogulis 
et al., 2005). We would expect to observe greater LDH concentrations with higher 
levels of aggregation suggesting further damage in cultured neurons incubated 
with α-synuclein oligomerised for longer periods of time.  
Finally, another limitation is that the low number of repetitions of experiments using 
α-synuclein oligomerised for 12h and 13h provided us with insufficient information 
to infer that the amount of oligomers present in these samples did not reach the 
concentration necessary to block LTP. Therefore, further work will be necessary 
to confirm that the effect of α-synuclein on LTP is caused by a time-dependent 
effect on the formation of toxic aggregates.  
3.4.2 Plasticity dysfunction in the absence of transmission dysfunction 
Our experiments show that sufficiently oligomerised α-synuclein inhibits LTP, 
therefore, we tested whether this inhibition was caused by an effect of α-synuclein 
oligomers inducing suboptimal depolarisation following HFS. The cumulative 
fEPSP amplitude following each train of 100 pulses at 100 Hz was not significantly 
different in the treated than control slices, thus it is unlikely that the α-synuclein 
oligomers-mediated inhibition of LTP was due to a reduced response to HFS. This 
is consistent with other results which indicate that Aβ does not have an effect on 
HFS induced depolarisation (Townsend et al., 2006). Therefore, the next step will 
be to identify which components of the LTP signalling cascade are involved in the 
inhibition of LTP mediated by α-synuclein.  
3.4.3 Distinct signalling pathways mediate protein aggregate synaptotoxicity 
Previously, it was shown that Aβ oligomers result in caspase-3-mediated cleavage 
of Akt, which prevents Akt from supressing the activity of GSK-3β, resulting in LTP 
impairment (Jo et al., 2011). In the same study, LTP was rescued by pre-
incubating slices with the GSK-3β inhibitor CT-99021. Therefore, to test whether 




pathway, we pre-incubated hippocampal slices with CT-99021 before incubating 
with α-synuclein oligomerised for 15 hours. Our data suggest that α-synuclein 
does not exert its inhibitory effect through GSK-3β activation. This is an interesting 
finding as it has been suggested that α-synuclein activates GSK-3β through 
phosphorylation at Tyr-216 following a parkinsonism-inducing neurotoxin 
MPP/MPTP, and that phosphorylated GSK-3 β is increased in samples from PD 
patients (Duka et al., 2009), and that α-synuclein stimulates autophosphorylation 
of GSK-3β (Kawakami et al., 2011). However, our results suggest that α-synuclein 
oligomers do not inhibit LTP via the caspase-3-GSK-3β pathway, as opposed to 
Aβ oligomers.  
Another significant aspect of protein aggregate pathogenesis is their effect on 
neuronal structure. As indicated previously, exposure to small Aβ oligomers 
resulted in altered spine morphology and reduced spine density in hippocampal 
neurons, and these effects were caused by oligomers, as exposure to monomers 
did not result in significant differences compared to controls (Lacor et al., 2007; 
Shankar et al., 2007). Furthermore, Aβ oligomers-mediated effects on spine 
density were prevented by the expression of a constitutively active isoform of 
cofilin, a filamentous actin severing protein (Shankar et al., 2007). As structural 
dendritic spine changes depend on actin dynamics, and they are tightly related to 
synaptic plasticity (Kasai et al., 2010), these findings indicate that dendritic spine 
pathology could underpin the loss of LTP. 
 
3.5 Conclusion 
These data tentatively indicate that the extent of protein aggregates per se – rather 
than the actual identity of the aggregated protein – might confer the impairing 
effects. Wider evidence suggests that pathological protein aggregates could 
fundamentally affect neuronal structure and the regulation of proteins that govern 
neuronal structure. Whether and how that links with the effects of aggregated 




Critically, how the regulation of neuronal structure itself contributes to the normal 
physiological expression of plasticity is still not fully understood. Therefore, in 
order to determine whether structural dysregulation links aberrant proteins and 
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Chapter 4 - The role of Group I PAKs in hippocampal synaptic function 
4.1 Introduction 
4.1.1 The regulation of neuronal structure 
Synapses are critical for signal transmission, and the majority of excitatory 
synapses form on dendritic spines which are small membrane protrusions on 
dendrites (Fiala et al., 2002). Although the shape and size of dendritic spines is 
variable, three main types of dendritic spines have been described: mushroom, 
thin, and stubby spines. Mushroom spines have narrow necks and large spherical 
heads, thin spines have a constricted neck and small heads, while stubby spines 
have similar neck length and width (Tada & Sheng, 2006).  
The major cytoskeletal component of dendritic spines is branched filamentous 
actin (F-actin) (Korobova & Svitkina, 2010). The arrangement of F-actin in 
dendritic spines is constantly subject to activity-dependent reorganisation. 
Changes in synaptic structure such as growth and shrinkage, synapse formation 
and pruning are regulated by signalling pathways acting on the actin 
polymerisation and depolymerisation. The main regulators of actin dynamics are 
the family of Ras homologous guanosine triphosphatases (Rho GTPases). These 
small GTPases are monomeric G-proteins which alternate between their active 
state (GTP-bound) and their inactive state (GDP-bound). Once active, they act as 
molecular switches activating subsequent elements of various signalling 
cascades.  
These changes are triggered during development, but also after learning and 
experience. Extracellular signals activate receptors which in turn activate key 
regulators of the actin cytoskeleton. It was shown that strong synaptic inputs 
activate three Rho GTPases: Rho (Ras homolog family member A), Rac1 (Ras-
related C3 botulinum toxin substrate 1), and Cdc42 (Cell division cycle 42) 
(Murakoshi et al., 2011). These GTPases have many effectors which participate 




effectors of Rho GTPases include several protein kinases and actin binding 
proteins (ABPs).  
ABPs have distinct roles in actin assembly, disassembly and stabilisation 
(Borovac et al., 2018). For instance, the Arp2/3 protein complex mediates actin 
polymerisation and branching (Mullins et al., 1998); cofilin induces actin filament 
depolymerisation, but it is inhibited by phosphorylation (Theriot, 1997); α-actinin 
facilitates the formation of cross-links between actin filaments and is involved in 
spine  maturation (Hodges et al., 2014); drebin mediates the clustering of actin 
fibres by regulating the activity of other ABPs and is involved in spine 
morphogenesis (Takahashi et al., 2003). Thus, various ABPs with different roles 
regulate the organisation of the actin cytoskeleton.  
Another class of Rho GTPase effectors are a family of proteins called p21-
activated kinases (PAKs), serine/threonine kinases which are activated by binding 
to Rac1 or Cdc42 (Manser et al., 1994).  PAKs phosphorylate and thereby activate 
LIM-domain-containing kinase (LIMK), which in turn phosphorylates cofilin, 
preventing it from severing actin filaments (Edwards et al., 1999). This pathway is 
important for cytoskeleton regulation as inactivating cofilin facilitates actin 
polymerisation. Furthermore, PAKs have been reported to mediate dendritic spine 
formation as expression of wild type PAK1 resulted in an increase in the number 
of dendritic spines, whereas inhibiting PAK1 activity produced the opposite effect 
(Zhang et al., 2005). These results suggest that PAKs might mediate the formation 
of spines by regulating cytoskeleton dynamics.  
Mounting evidence suggests that synaptic plasticity is accompanied by dynamic 
actin cytoskeleton changes, however, the precise links between structure-





4.1.2 Molecular mechanisms of LTP 
Glutamate receptors are crucial for the expression of LTP. First, there should be 
a sufficient amount of glutamate to bind and activate AMPARs. This in turn 
depolarises the postsynaptic neuron which repels the NMDARs Mg2+ ions block 
the ion channel pore of these receptors. Then Na+, K+ and Ca2+ flow into the cell. 
Calcium is an important part of many signalling cascades; after NMDARs are 
activated there is a fast influx of calcium in the postsynaptic neuron. Calcium ions 
bind to the messenger protein Calmodulin or CaM (calcium-modulated protein), 
which senses intracellular calcium concentration and then transduces signals to 
various downstream proteins. One of the most important of those proteins for 
synaptic plasticity is calcium-calmodulin-dependent kinases (CaMK). These 
kinases are serine/threonine kinases; as their name implies, their activation 
depends on binding of Ca2+-calmodulin, but CaMKs can remain activated after 
they have been activated and autophosphorylated. These kinases are crucial to 
LTP expression because once they have been activated, CaMKIIs phosphorylate 
GluA1 subunits of AMPARs which increases their conductance and increases 
their trafficking to the postsynaptic membrane where they can be activated by 
glutamate release, leading to increased postsynaptic potentials (Lisman et al., 
2012). 
Receptor changes at the synapse are ultimately underpinned by changes to the 
physical structure of the synapse and the neuron. It has been shown that a positive 
correlation between spine volume and the amount of AMPARs (Matsuzaki et al., 
2001). Indeed, such physical changes in size and shape are governed by a distinct 
set of mechanisms that respond to the need for structural changes during synaptic 
plasticity. 
 
4.1.3 Structural changes in synaptic plasticity 
Synaptic plasticity has been regarded as the cellular basis for learning and 




synaptic networks may also have functional implications for learning and memory 
(Caroni et al., 2012). Recent studies have reported a strong relationship between 
synaptic plasticity and morphology changes of dendritic spines (Bosch & Hayashi, 
2012; Kasai et al., 2010). Glutamate release triggered by glutamate uncaging or 
HFS induces a rapid input-specific enlargement of dendritic spines (Matsuzaki et 
al., 2004; Okamoto et al., 2004). Furthermore, the enlargement in dendritic spine, 
referred to as structural LTP (sLTP), shares similarities with the induction of LTP. 
For instance, dendritic spine enlargement is also dependent on the activation of 
NMDARs as it is prevented by the NMDAR antagonist AP5, it is associated with 
increased AMPAR current increase, and it is long-lasting (Matsuzaki et al., 2004). 
There is also experimental evidence suggesting that both LTP and dendritic spine 
enlargement share components of signalling cascades, as blocking CaM, CaMKII, 
and actin filament polymerisation blocks LTP induction and spine enlargement 
(Fukazawa et al., 2003; Krucker et al., 2000; R C Malenka et al., 1989; R Malinow 
et al., 1989; Matsuzaki et al., 2004).   
The aforementioned studies and additional experiments suggest that there is 
substantial overlap between the signalling pathways implicated in LTP and sLTP. 
One potential link between these two aspects of synaptic plasticity are PAKs. In 
terms of LTP, it has been shown that LTP induction using TBS results in increased 
phosphorylation of PAK (L. Y. Chen et al., 2007). Furthermore, this 
phosphorylation of PAKs might be necessary for LTP induction, as knocking out 
or supressing expression of Group I PAKs results in LTP impairment (Asrar et al., 
2009; Boda et al., 2004; Meng et al., 2005). However, other experiments observed 
that suppressing PAK1 activity leads to increased potentiation compared to 
controls in the forebrain, but has no effect on hippocampal LTP (M. L. Hayashi et 
al., 2004). Thus, the precise reasons for why and how PAKs are important for LTP 






4.2 Aims and Hypotheses 
Characterise the role of Group I PAKs in synaptic plasticity under non-pathological 
conditions. Synaptic dysfunction is one of the first steps in the progression of 
neurodegenerative diseases (Hardy & Selkoe, 2002), and many studies have 
found abnormalities in dendritic spines associated with cognitive disorders, such 
as mental retardation, schizophrenia, in addition to Alzheimer’s disease (Holtmaat 
& Svoboda, 2009). Considering that synaptic plasticity is closely related to 
structural plasticity and cytoskeletal changes, the aim of this study is to 







4.3.1 Group I PAKs are required for hippocampal LTP 
Various studies have reported altered late-phase LTP in the hippocampus and 
deficits in learning and memory in animals or brain slices deficient in PAK1 and 
PAK3 expression (Asrar et al., 2009; Boda et al., 2004; M. L. Hayashi et al., 2004; 
Meng et al., 2005). Since our aim is to identify the role of PAKs in synaptic 
plasticity, we used the Group I PAKs pharmacological inhibitor IPA-3 to examine 
whether pharmacological PAK inhibition would also produce deficits in LTP. 
Therefore, we examined LTP in hippocampal slices following incubation in aCSF 
with IPA-3 at 25 µM for an hour prior to recording and perfused during recording. 
Whilst LTP could be readily induced in control slices (control, 150 ± 9% of 
baseline, n = 8, Figure 4.1A), LTP was significantly reduced in incubated and 
perfused slices compared to controls assessed at 55 minutes after HFS (IPA-3: 
125 ± 8% of baseline, n = 7; control, 161 ± 7%, n = 8,  p = 0.004, Figure 4.1B) 
and at 115 minutes after HFS (IPA-3: 115 ± 8% of baseline, n = 7, closed circle; 
control, 150 ± 9%,  n = 8, open circles, p = 0.012, Figure 4.1B). Thus, these results 















Figure 4.1 LTP is impaired in IPA-3 treated hippocampal slices. A.
LTP can be induced in control slices (n = 8). B. Incubation of slices with
IPA-3 (a group I PAK inhibitor, at 25 mM) for 1 hour before recording and
perfusion of the drug in aCSF during baseline (n = 7. Tme after HFS:
55m minutes p = 0.004, 115 minutes p = 0.012). All symbols represent
the mean ± SEM. Inset represents traces of fEPSPs recorded and






















































































4.3.2 Group I PAK inhibitor does not affect basic synaptic function 
We were next interested in understanding why inhibition of Group I PAKs impaired 
LTP. One possible explanation is that treatment of slices with the PAK inhibitor 
IPA-3 impairs fundamental synaptic function, which could prevent normal 
physiological signalling and therefore LTP expression. Paired pulse facilitation is 
a form of short-term plasticity which depends on presynaptic function and it is 
measured by the ratio of the slope of the second stimulus by the slope of the first 
(Byrne & Roberts, 2009). Changes to this form of plasticity as well as basal 
synaptic strength are likely to alter LTP (Roberto Malinow & Malenka, 2002). 
Therefore, we examined whether pharmacological inhibition of group I PAKs 
affected pre-synaptic function by comparing paired-pulse ratios (PPR). We found 
that there was no significant difference in PPRs between slices incubated in IPA-
3 for 1 hour and perfused slices versus controls (IPA-3: PPF at 50 ms intervals: 
1.76 ± 0.08, n = 7; controls: PPF at 50 ms intervals: 1.76 ± 0.06, n = 8; two-way 
ANOVA p = 0.198, Figure 4.2A). These results indicate that presynaptic 
neurotransmitter release was not affected by group I PAK inhibition, and therefore 
impairment to LTP induction is unlikely to be explained by changes to presynaptic 
function. 
Basal synaptic strength is an important property of synaptic physiology, therefore, 
we sought to assess whether inhibiting group I PAKs with IPA-3 affected synaptic 
transmission. For this purpose, we measured basal synaptic strength by recording 
fEPSPs and presynaptic volley evoked by various stimulation intensities. As the 
presynaptic volley represents the presynaptic action potentials occurring near the 
recording electrode, its magnitude conveys information about the number of axons 
firing action potentials, which allows us to compare fEPSP slope between different 
slices (Byrne & Roberts, 2009). Therefore, if the presynaptic volley/fEPSP 
relationship increases, it would mean that synaptic transmission is increased. 
However, as shown in Figures 4.2B and 4.2C we found no differences between 
controls and slices incubated with IPA-3 for an hour and perfused with the drug 




control slices and 0.55 ± 0.05 mV/ms (n = 7) in IPA-3 incubated and perfused 
slices (two-way ANOVA p = 0.726). Thus, these results suggest that IPA-3 does 





Figure 4.2 No observed effect of IPA-3 incubation and perfusion on short term
plasticity or synaptic efficacy. Slices were incubated with IPA-3 (25 mM) for 1 hour
before and perfused during recording (IPA-3, n = 7; control, n = 8). A. Representative
fEPSPs traces evoked by paired-pulse-stimulation. B. Paired-pulse ratios were not
significantly different in incubated slices compared to controls (two-way ANOVA p =
0.198). C. Examples of fEPSPs of CA1 synapses at increasing stimulation strengths. D.
No significant difference was found in fEPSP slopes at various stimulation intensities E.
Input-output curves were not significantly different in incubated slices compared to
controls (Control Slope: 0.49 ± 0.05 mV/msec; IPA-3 Slope: 0.55 ± 0.05 mV/msec; two-












































































4.3.3 Group I PAK inhibition does not affect cumulative depolarisation evoked by 
tetanic stimulation 
As indicated in the previous chapter (section 3.3.2), LTP induction stimulation 
patterns are required to produce a sufficiently strong depolarisation to produce 
stable long-term potentiation. Hence, a possible explanation for Group I PAK 
inhibition effect on LTP may be that it lessened the amplitude of fEPSPs evoked 
by HFS, thereby impairing LTP. To test this hypothesis, we calculated the 
cumulative amplitude of responses elicited by HFS in control slices and in slices 
incubated and perfused with IPA-3 analysing data from the results in section 4.3.1. 
 
Overall, Group I PAK inhibition did not produce significant differences in 
cumulative fEPSP amplitude profiles when compared to untreated slices in 
response to tetanus 1 (IPA-3: 3202 ± 149% of the first fEPSP, n = 7, purple; 
Control: 3082 ± 196%, n = 8, black, p = 0.641, Figure 4.3, left) or tetanus 2 (IPA-
3: 2166 ± 131% of the first fEPSP, n = 7, purple; Control: 2244 ± 150%, n = 8, 
black, p = 0.704, Figure 4.3, right). It can therefore be assumed that the inhibition 
of LTP resulting from the application of a Group I PAK inhibitor was not caused by 






Figure 4.3 PAK inhibition does not affect the cumulative
depolarisation evoked by tetanic stimulation. The cumulative pulse
amplitude expressed as the fold increase from the first pulse amplitude
in each train of high-frequency stimulation (two trains of 100 pulses, 100
Hz) in control slices (black symbols) and in slices incubated for 1 hour
and perfused during baseline with IPA-3 (25 µM). Data from Fig 4.1; all





4.3.4 Group I PAKs are not required for hippocampal LTP maintenance 
It is thought that components of LTP, such as induction, expression and 
maintenance involve different molecular events (R C Malenka & Bear, 2004). 
Therefore, as it is apparent that inhibiting PAKs leads to LTP impairment, the next 
step was to examine whether IPA-3 inhibits LTP at a particular phase. To test this, 
we applied IPA-3 10 minutes after delivering high frequency stimulation to the 
Schaffer collateral pathway but found no significant difference between perfused 
slices and controls (IPA-3: 141 ± 4% of baseline, closed circles, n = 6; control: 149 
± 10%, n = 5, open circles, p = 0.449, Figure 4.4A). We also applied IPA-3 10 
minutes before tetanus but the results match the previous experiment (IPA-3: 133 
± 8% of baseline, closed circles, n = 5; control 126 ± 10%, n = 6, open circle, p = 
0.577, Figure 4.4B). Taken together, these results indicate that PAK inhibition 






Figure 4.4 LTP maintenance was not impaired by PAK inhibition.
LTP is similar in control slices and slices perfused with IPA-3 (a group I
PAK inhibitor, at 25 mM). A. Perfusion of IPA-3 10 minutes after tetanus
(IPA-3: 141± 4% of baseline, closed circles, n = 6; control: 149± 10%,
n = 5, open circles, p = 0.449). B. Perfusion of IPA-3 10 minutes before
tetanus (IPA-3: 133 ± 8% of baseline, closed circles, n = 5; control 126
± 10%, n = 6, open circle, p = 0.577).










































































4.3.5 Strong tetanus stimulation is not sufficient to induce LTP following Group I 
PAK inhibition 
The BCM (Bienenstock, Cooper and Munro) theory of modification states that 
when a pattern of activity is stronger than the “modification threshold” potentiation 
occurs at the active synapses, but when the pattern of activity is weaker than the 
threshold active synapses undergo depression (Bear, 1996). Accordingly, 
inhibition of LTP by Group I PAKs may be caused by a shift in the modification 
threshold of synapses treated with the drug, then increasing tetanic stimulation 
may rescue LTP. Studies have shown that an LTP induction protocol using 4 trains 
of HFS produces a form of strong L-LTP which lasts for more than 3 hours (Alarcon 
et al., 2006; Y.-Y. Huang et al., 2005; Y. Y. Huang & Kandel, 1994; Pavlowsky & 
Alarcon, 2012; Villers et al., 2012). Therefore, to test whether Group I PAK 
inhibition on LTP is prevented by stronger tetanic stimulation, we induced LTP by 
4 trains of 100 Hz (separated by 30 sec intervals) in slices incubated with IPA-3 
(25 µM) for 1 hour prior to recording and perfused during recording and in 
untreated, control slices. As can be seen in Figure 4.5, inhibition of Group I PAKs 
resulted in decreased LTP compared to controls (IPA-3: 90 ± 12% of baseline, n 
= 3, closed circle; control: 130 ± 6%, n = 3, open circles, p = 0.044). These results 
suggest that Group I PAKs may have a role in LTP induction rather than increasing 
the threshold for LTP induction. 
As in section 4.3.3, it may be the case that depolarisation following the trains of 
HFS was not sufficient to induce LTP. Therefore, we compared the cumulative 
fEPSP amplitude produced by each of the 4 trains of HFS, but found no 
differences between the slices incubated with the Group I PAK inhibitor compared 
to controls in response to tetanus 1 (IPA-3: 3061 ± 592% of the first fEPSP, n = 3, 
red; Control: 3226 ± 331%, n = 3, black, p = 0.821, Figure 4.6, top left), tetanus 
2 (IPA-3: 2127 ± 147%, n = 3, red; Control: 2202 ± 201%, n = 3, black, p = 0.779, 
Figure 4.6, top right), tetanus 3 (IPA-3: 1501 ± 188%, n = 3, red; Control: 2244 ± 




269%, n = 3, red; Control: 2587 ± 657%, n = 3, black, p = 0.556, Figure 4.6, 
bottom right). It can thus be suggested that HFS-induced depolarisation was not 
the factor responsible for the inhibition of L-LTP in slices which were incubated 
and perfused with IPA-3.  
  















































Figure 4.5 Strong LTP is blocked by PAK inhibition . LTP is inhibited
in slices pre-incubated for 1 hour and perfused during baseline with IPA-






Figure 4.6 PAK inhibition does not affect the cumulative depolarisation
evoked by 4 trains of HFS. The cumulative pulse amplitude expressed as
the fold increase from the first pulse amplitude in each train of high-
frequency stimulation (four trains of 100 pulses, 100 Hz) in control slices
(black symbols) and in slices incubated for 1 hour and perfused during
baseline with IPA-3 (25 µM, purple symbols). Data from Fig 4.5; all values
are expressed as means ± SEM (T1: p = 0.821; T2: p = 0.779; T3: p =






4.3.6 Group I PAK inhibition does not change LTP threshold 
As inhibition of Group I PAKs impaired LTP in slices stimulated with both 2 and 4 
trains of HFS, it was hypothesised that these effects might be explained by a 
change in the modification threshold (described in the previous section) in favour 
of synaptic depression. To test this hypothesis, we applied a subthreshold LTP 
induction stimulus (20 pulses at 100Hz) to untreated slices and to slices incubated 
for 1 hour and perfused during baseline with IPA-3. However, as can be seen in 
Figure 4.7, no significant differences were found between the two groups (IPA-3: 
96 ± 9% of baseline, n = 5, closed circle; control: 89 ± 2%, n = 6, open circles, p = 
0.126). This finding suggests that the modification threshold was not affected, 
therefore inhibition of Group I PAKs effect on LTP might be caused by other 






Figure 4.7 PAK inhibition has no effect on LTP induction threshold.
Responses in control and slices pre-incubated and perfused with IPA-3
were similar after 1 train of 20 pulses of 100Hz (n = 3 slices from 3
animals, p = 0.126).


















































4.3.7 Group I PAK inhibitor FRAX does not affect LTP 
To validate the effects of group I PAK inhibition on LTP induction a different 
inhibitor was used. FRAX486, a selective group I PAK inhibitor, was discovered 
by performing a high-throughput screen of a 12,000 kinase-focused small library 
and was found to alleviate abnormalities in dendritic spines in a mouse model of 
fragile X syndrome (Dolan et al., 2013). Surprisingly, LTP in slices incubated and 
perfused with FRAX486 at a concentration of 500 nM impaired LTP but the result 
was not statistically significant (FRAX: 141 ± 8% of baseline, n = 5, closed circles; 
control 161 ± 5%, n = 6, open circles, p = 0.056, Figure 4.8A). To test whether 
the concentration used was sufficient to produce the necessary group I PAK 
inhibition to affect LTP, we incubated slices in aCSF with FRAX486 at a 
concentration of 1 µM, however, the results were similar in control and incubated 
slices (FRAX: 132 ± 2% of baseline, n = 8, closed circles; control 139 ± 5%, n = 7 
open circles, p = 0.189, Figure 4.8B), however, this could be explained by low 
LTP levels in controls. This suggests that pharmacological inhibition of group I 














Figure 4.8 Group I PAK inhibitor FRAX486 has no effect on LTP.
Slices were incubated with FRAX486 at 500 nM and 1 μM, for 1 hour
before recording and perfusion of the drug in aCSF during baseline did
not significantly change potentiated responses after tetanus A (p =
0.056) and B (p = 0.189), respectively.
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4.3.8 Cdc42 activator does not affect LTP induction 
It is known from the literature that bradykinin activates the GTPase Cdc42 (Kozma 
et al., 1995), which is an activator of PAKs. In previous research bradykinin was 
used at a concentration of 85 nM to investigate the effect of Cdc42 activation on 
synaptic maturity in hippocampal neuronal cultures (Shen et al., 2006). Therefore, 
we used bradykinin to test whether PAK activation by Cdc42, would increase LTP. 
To do this, we incubated slices in aCSF with bradykinin 85 nM for 30 min prior to 
recording but there was no difference between incubated slices and controls 
(Bradykinin: 142 ± 4% of baseline, n = 3, closed circles; control 144 ± 6%, n = 3 
open circles, p = 0.756, Figure 4.9A) or in slices incubated for 30 minutes and 
perfused with bradykinin during baseline (Bradykinin: 141 ± 10% of baseline, n = 
4, closed circles; control 146 ± 4%, n = 4 open circle, p = 0.549, Figure 4.9B). In 
addition, to test whether the effects of Cdc42 activation occurred during late-phase 
LTP, we incubated the slices with bradykinin at a higher concentration (500 nM) 
for 30 min and perfused during baseline and recorded for 2 hours after delivering 
high frequency stimulation. As can be seen from Figure 4.10, there was no 
significant difference between incubated slices and controls (Bradykinin: 114 ± 4% 
of baseline, n = 8, closed circles; control 119 ± 6%, n = 8 open circles, p = 0.574, 















Figure 4.9 Bradykinin has no effect on LTP. A. Incubation of slices in
Cdc42 activator Bradykinin (85 nM) does not affect LTP. Slices were
incubated for 30 minutes before recording (n = 3, p = 0.756). B. Slices
were incubated for 30 minutes before recording and bradykinin (85 nM)
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Figure 4.10 Cdc42 activator has no effect on LTP at high
concentration. Slices incubated with Bradykinin for 30 minutes before
recording and bradykinin was perfused during baseline were potentiated
at a level similar to control slices (n = 8, p = 0.574).
















































4.4.1 Group I PAKs and LTP induction 
As was mentioned earlier, there might be interplay between Group I PAKs and the 
mechanisms of LTP induction. Previous experiments have indicated that Group I 
PAKs have a role in spine morphology changes, as well as in synaptic 
transmission and plasticity (Asrar et al., 2009; Boda et al., 2004; Chen et al., 
2007b; Hayashi et al., 2004; Meng et al., 2005). The latter studies used genetic 
techniques, such as gene knockdown, interference RNA, or expression of 
dominant-negative proteins to suppress PAKs, while we inhibited PAKs using 
pharmacological inhibitors in our experiments. The use of pharmacological 
inhibitors allowed us to analyse the effect of PAK function on LTP maintenance. 
Our results suggest that inhibiting Group I PAKs 10 minutes before or after LTP 
induction does not affect LTP maintenance.  
However, one key issue with our experiments is that we did not test activation of 
Group I PAKs following HFS. Other studies have shown that PAK phosphorylation 
peaks 7 minutes after the induction of LTP using TBS (Chen et al., 2007b; Rex et 
al., 2009). These findings suggest that if the pattern of activation of Group I PAKs 
is similar in LTP induced by HFS, infusing IPA-3 10 minutes after HFS would be 
rather late to observe an effect on maintenance. Another possibility is that 
perfusing IPA-3 10 minutes before HFS does not provide sufficient time for the 
drug to effectively suppress Group I PAKs.  
Although our results indicate that PAKs are not necessary for maintenance, 
another alternative is that PAK signalling may be required for LTP stabilisation. It 
has been reported that Latrunculin A, which prevents F-actin polymerisation, 
inhibits LTP maintenance when infused within 10 minutes after TBS (Rex et al., 
2009). In the same study, infusion of a low concentration of the Group I PAK 
inhibitor IPA-3 (2 µM) for 50 minutes before TBS and until the end of the 
experiment did not affect LTP. However, infusing latrunculin A 30 minutes after 




latrunculin A alone has a time window of 10 minutes, these results suggest that 
LTP induction requires actin filament assembly, and that inhibition of PAKs 
perturbs F-actin stabilisation. Therefore, it would be interesting to test whether 
infusion of latrunculin A produces similar effects on LTP induced by HFS. 
 
4.4.2 No effect of FRAX486 on LTP induction 
As discussed above, PAKs have been found to have a role in LTP, and our results 
were consistent with the literature as using IPA-3 to inhibit Group I PAKs resulted 
in LTP impairment. However, when using the Group I PAK inhibitor FRAX486, 
incubating and perfusing slices in the same manner as with IPA-3, we observed 
no effect on LTP. Indeed, both IPA-3 and FRAX486 have been reported to inhibit 
all three Group I PAK isoforms (Deacon et al., 2008; Dolan et al., 2013). Therefore, 
it is somewhat surprising that the pharmacological inhibitor FRAX486 had no 
effect on LTP. 
Our results may be explained by FRAX486 producing insufficient PAK inhibition 
necessary to result in LTP impairment. Although dose-response curves of PAK 
activity in vitro suggest that the concentrations of FRAX486 used in our 
experiments would inhibit all three Group I PAKs (Dolan et al., 2013), this assay 
tests kinase activity in isolation; whereas a more complex environment such as 
hippocampal slices could require a higher concentration or longer incubation time 
to produce alterations in LTP. This hypothesis is supported by a study in which 
suppression of PAK1 activity using transgenic mice expressing a dominant 
negative isoform of PAK1 resulted in increased potentiation in the cortex and 
normal LTP in the hippocampus (Hayashi et al., 2004). In the same study, it was 
found that PAK activity levels were reduced in the cortex to a greater extent than 
in the hippocampus. Furthermore, the observed levels of activated PAK were 
similar in the cortex of wild type mice and in the hippocampus of transgenic mice. 
The contradictory LTP results by Hayashi et al were attributed to PAK inhibition 




Despite these contradictory results, further research could be done testing activity 
levels of Group I PAKs in hippocampus slices incubated with different 
concentrations of FRAX486 and IPA-3 to confirm their efficacy.  
 
4.5 Conclusion 
The results of this investigation support the idea that PAKs may have a specific 
role in LTP induction, as inhibiting Group I PAKs with IPA-3 had an adverse effect 
on LTP induction, but no effect on LTP maintenance. However, the precise 
mechanism used by PAKs in LTP induction remains to be elucidated. Therefore, 
it is necessary to assess if and how PAKs interact with crucial components of 
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Chapter 5 - The effect of PAK inhibition on cellular functions underlying LTP 
induction 
5.1 Introduction 
5.1.1 The form and function of field excitatory postsynaptic potentials 
The synchronous responses evoked by activation of a population of neurons in 
the hippocampus can be measured as field potentials, and if these potentials are 
measured extracellularly, they are known as field excitatory postsynaptic 
potentials (fEPSPs) (Andersen et al., 1978). These fEPSPs consist of an early 
component, a rapid decline in voltage mediated by the influx of ions through the 
AMPAR channel, and a late component elicited by the influx of ions through 
NMDARs (Spruston et al., 1995). The preferred measurement to assess recorded 
fEPSPs is the initial slope, as it is less prone to be altered by other sources of 
current in brain slices compared to peak amplitude (Sweatt, 2010). However, there 
are other quantitative indices of fEPSP shape that can be used to compare 
neuronal responses (these waveform shape indices of fEPSPs are depicted in 
Figure 5.1). In fact, a study by Petersen et al. analysed fEPSP waveform kinetics 
as method to distinguish whether responses were from the medial or the lateral 
perforant path inputs to the dentate gyrus (Petersen et al., 2013).  
The fEPSP waveform parameters included in the study by Petersen et al. were 
onset latency, which is the time measured from when the stimulus is delivered to 
“foot” of the fEPSP (the point at which the fEPSP initial deflection can be detected); 
the peak latency which is the time measured from the time values of the foot to 
the peak of the fEPSP; and the half-width, which is defined as the duration of the 
fEPSP at half its peak amplitude. Changes in fEPSP parameters may indicate 
changes in receptor conductances (Fuenzalida et al., 2007). Measuring fEPSP 
kinetics may give insights into the kinetic properties of synaptic conductance which 
can affect how synapses integrate signals to produce enduring changes in 




5.1.2 The role of calcium in LTP 
NMDARs are highly permeable to Ca2+ (Jahr & Stevens, 1987), and they are 
critical for the induction of LTP (Bliss & Collingridge, 1993). The requirement of 
NMDAR activation was explained by experiments in which preventing a rise in 
Ca2+ by loading the Ca2+ chelator, EGTA, into neurons resulted in the LTP 
inhibition (Lynch et al., 1983). Further evidence came from a study by Malenka et 
al, where synaptic potentiation occurred in hippocampal neurons using a 
photolabile chelator, nitr-5 preloaded with Ca2+, which releases Ca2+ in response 
to ultraviolet light; whereas non-photolysed nitr-5 blocked LTP induction; in 
addition, the same researchers found that preventing Ca2+ influx by depolarising 
the postsynaptic neuron also prevented LTP (R C Malenka et al., 1988).  
Prior studies have noted that a brief high rise in intracellular Ca2+ in the 
postsynaptic site initiates biochemical processes necessary for LTP induction, 
whereas prolonged lower concentrations of Ca2+ influx activate processes needed 
for LTD (Artola & Singer, 1993; S.-N. Yang et al., 1999). The calcium-dependent 
processes are amplified by many proteins that are activated or inactivated by Ca2+, 
such as calmodulin (CaM), Ca2+/calmodulin-dependent protein kinase II (CaMKII), 
calcineurin and protein kinase C (PKC). The change in synaptic transmission is 
determined by which Ca2+-binding proteins are activated following Ca2+ influx. For 
instance, a molecular cascade for LTP is initiated by Ca2+ influx through activated 
NMDARs, then Ca2+ binds to CaM complex, which in turn leads to the 
phosphorylation and thereby activation of CaMKII. Then, active CaMKII 
phosphorylates and potentiates AMPAR-mediated responses at the synapse 
(Barria et al., 1997). Furthermore, loss of CaMKII decreases AMPAR-mediated 
EPSCs and inhibits LTP (Incontro et al., 2018). Therefore, Ca2+ influx and the 
subsequent biochemical processes triggered by Ca2+ are necessary for the 





5.1.3 Dynamic changes in spine structure 
As explained earlier, the morphology changes in dendritic spines is dependent on 
actin cytoskeleton rearrangements. Indeed, in vivo visualisation of dendritic spines 
revealed that changes in shape are driven by actin dynamics (Fischer et al., 1998). 
The molecular events that are thought to underlie experience-dependent 
morphology changes in dendritic spines have been previously described in 
sections 1.5.1, 1.5.2 and 4.1.1. 
In addition to experience-dependent changes in morphology, LTP is associated 
with the persistent enlargement of dendritic spines, termed structural LTP (sLTP) 
(Nakahata & Yasuda, 2018). Previous studies have shown that LTP induction 
using high-frequency stimulation, glutamate uncaging or chemically-induced LTP 
(chemLTP), produces dynamic changes in dendritic spine morphology (Engert & 
Bonhoeffer, 1999; Kopec et al., 2006; Maletic-Savatic et al., 1999; Okamoto et al., 
2004). For example, theta burst stimulation (TBS) paired with postsynaptic 
depolarisation induced an increase of spine volume which persisted for 45 minutes 
after TBS as well as LTP (Yang et al., 2008); tetanic stimulation induced 
enlargements in dendritic spine head size that persisted for 30 minutes after 
stimulation (Matsuzaki et al., 2004; Okamoto et al., 2004); glutamate uncaging 
caused a long-lasting increase in spine head diameter (Matsuzaki et al., 2004) 
and it promoted the persistence of newly formed spines following the LTP-inducing 
stimuli (Hill & Zito, 2013); Chemically-induced LTP using bath application of 
glycine also produces long-term spine enlargement (Fortin et al., 2010; Park et al., 
2006). These results suggest that both functional and structural forms of plasticity 
occur in stimulated synapses, however, whether and how spine remodelling 
supports LTP is still not fully understood.  
Interestingly, PAKs may be involved in structural changes in dendritic spines that 
lead to increased content of AMPARs on the synaptic surface. It has been shown 
that the expression of GluA1 and GluA2 AMPAR subunits at the synaptic surface 
increases following chemLTP stimulation protocols (Groc et al., 2008; Kopec et 




AMPARs are not completely understood. However, researchers have identified a 
novel signal transduction pathway in which phosphorylation of GluA1 AMPAR 
subunits by PAK3 increases expression of these subunits at the synaptic surface 
in neurons (Hussain et al., 2015). This finding suggests that PAKs might have a 
role in different mechanisms necessary for LTP induction, regulation of AMPAR 
expression at the synapse as well as the control of dendritic spine structural 
changes. Therefore, this chapter will examine the impact of PAK inhibition on 
spine morphology changes and AMPAR trafficking to the synaptic surface. 
The chemLTP protocol is increasingly being used to assess synaptic plasticity 
related changes as it shares several features with LTP induced by high-frequency 
stimulation. ChemLTP is dependent on NMDAR activation, it requires Ca2+ influx 
and CaMKII activation, it is accompanied by the incorporation of AMPARs at the 
synaptic surface mediated by exocytosis, actin cytoskeleton rearrangements, and 
it is associated with potentiated excitatory signals (Kopec et al., 2006; Lu et al., 
2001). Thus, the glycine-induced form of chemical LTP was selected in order to 
identify the effects of PAK inhibition on LTP. 
5.2 Aims and Hypotheses 
In the previous chapter, our results indicated that pharmacologically inhibiting 
Group I PAKs using IPA-3 resulted in LTP impairment. However, the second 
inhibitor, FRAX486, did not produce any change in LTP magnitude. Therefore, the 
aim of this chapter is to analyse the effects of these PAK inhibitors on components 
of the signalling cascades leading to LTP induction, such as intracellular calcium 







5.3.1 Group I PAK inhibition does not affect fEPSP waveform 
The fEPSP waveform features can be measured to assess whether there are 
changes in postsynaptic receptor kinetics that can affect synaptic integration 
(Petersen et al., 2013). Therefore, we performed an analysis of the kinetics fEPSP 
recorded from control (untreated) and IPA-3 treated slices. The fEPSP waveform 
measurements were taken from data from Figure 4.1A and Figure 4.1B 5 minutes 
before HFS, and 5 minutes before the end of the experiments. The parameters 
measured included onset latency, peak latency, half-width, and decay time (see 
Figure 5.1). The onset latency, width at half-amplitude, decay time and decay 
slope of responses from both groups were not significantly different (Figure 5.2 
and Table 5.1). However, peak latencies were significantly longer in slices 
incubated and perfused with IPA-3 (Figure 5.2 and Table 5.1). This is consistent 
with our previous experiments in which LTP was inhibited following Group I PAK 
inhibition suggest that inhibition of Group I PAKs by IPA-3 incubation attenuates 





Figure 5.1 Field EPSP parameters. Representative
fEPSP waveform. Measurements of field excitatory
postsynaptic potentials: Baseline (a), half-width (b),
amplitude (c), onset latency (d), peak latency (e), and
decay time (f). Peak amplitude (mV) was calculated from
the DC baseline and the slope was measured by defining






Table 5.1 Summary of fEPSP kinetics parameters before and after HFS for control and IPA-
3 treated slices. The data were taken from experiments from Figure 4.1A (n = 8) and Figure 4.1B 
(n = 7). Values are means ± SEM (msec). Statistical significance between control and IPA-3 set at 
p < 0.05, tested using two-way ANOVA (denoted by an asterisk). 
 Onset latency Peak latency Half-width Decay time 
Before HFS     
Control 1.72 ± 0.06 1.59 ± 0.09 3.80 ± 0.19 13.96 ± 0.95 
IPA-3 1.68 ± 0.07 1.80 ± 0.11 3.80 ± 0.13  13.07 ± 0.80 
     
After HFS       
Control 1.68 ± 0.07 1.42 ± 0.06 3.38 ± 0.30 12.70 ± 1.21 
IPA-3 1.71 ± 0.06 1.77 ± 0.13 3.09 ± 0.12 13.45 ± 1.27 







Figure 5.2 Field EPSP parameters before and after HFS.
The onset latency, width at half-amplitude, and decay time





5.3.2 Transient Group I PAK inhibition does not induce calcium flux 
Changes in intracellular calcium concentration occur in many cellular signalling 
cascades. In neurons, calcium entry through NMDARs is necessary for LTP 
induction (Bliss & Collingridge, 1993). Moreover, blocking calcium release from 
intracellular stores lead to a inhibition of LTP induction but not maintenance 
(Harvey & Collingridge, 1992). In our previous electrophysiology results, LTP was 
inhibited by IPA-3 but not by FRAX486; this effect might be explained by IPA-3 
altering Ca2+ entry to neurons. Therefore, we performed calcium imaging to 
evaluate whether inhibition of group I PAKs affected intracellular Ca2+. Fluo4-AM, 
a chemical calcium indicator was used to observe calcium concentration changes 
in primary cultured hippocampal neurons (DIV 14-29). Following Fluo4-AM 
loading, neurons were placed in the recording chamber, then perfused with HBS 
buffer to measure baseline fluorescence of 10 minutes before bath application of 
IPA-3, FRAX486 or vehicle (DMSO) for 10 minutes. Neither, IPA-3 FRAX486 nor 
DMSO application produced changes in fluorescence intensity, see Figure 5.3, 
Figure 5.4 and Figure 5.5 (IPA-3: 99 ± 6% of baseline, n = 6 coverslips, 42 
neurons, FRAX486: 107 ± 5%, n= 3 coverslips, 49 neurons, DMSO: 95 ± 2%, n = 
9 coverslips, 38 neurons, p > 0.05); whereas, KCl application to neurons in all 
experimental groups led to a similar increase in fluorescence intensity which is 
consistent with previous studies (Cameron et al., 2016). These results suggest 
that application of group I PAK inhibitors IPA-3 or FRAX486 do not alter 
intracellular calcium signals, therefore, the effect of IPA-3 inhibition of LTP cannot 












Figure 5.4 Intracellular calcium concentration is not
affected by Group I PAK inhibitor FRAX486. Primary
cultured hippocampal neurons (DIV 14-29) were incubated
in 5mM Fluo4 AM for 60 min. After a baseline of 10 min,
FRAX486 (500 nM) was perfused (n = 11 coverslips, 49
neurons). The background intensity was subtracted from
fluorescence intensity of ROIs at all time points (each time
point refers to 1 frame at 30 sec intervals).
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Figure 5.5 Intracellular calcium concentration is not
affected by vehicle, DMSO. Primary cultured hippocampal
neurons (DIV 14-29) were incubated in 5mM Fluo4 AM for
60 min. After a baseline of 10 min, DMSO was applied as
a control (n = 9 coverslips, 38 neurons). The background
intensity was subtracted from fluorescence intensity of
ROIs at all time points (each time point refers to 1 frame at
30 sec intervals).


















































5.3.3 Group I PAK inhibition does not cause structural modifications 
Prior studies that have noted the importance of Group I PAKs in dendritic spine 
morphology. For instance, mutations that inhibit PAK3 kinase activity alter spine 
morphology and decrease spine density (Kreis et al., 2007). Moreover, inhibition 
of PAK3 in rat cultured hippocampal slices resulted in activity-dependent 
increased numbers of unstable spines and reduced spine stabilisation stabilization 
(Dubos et al., 2012). Thus, to determine whether disturbing Group I PAKs function 
alters spine morphology thereby resulting in LTP impairment, we incubated 
primary cultured hippocampal neurons (DIV 21) with DMSO (control), IPA-3 (25 
µM) or FRAX486 (500 nM) before fixing and staining these samples with phalloidin 
to analyse the area of protrusions on 10 µm2 dendritic sections. However, no 
significant difference was observed between the groups (Control: 0.53 ± 0.05 
Area(µm2) n = 3 coverslips, 8 neurons; FRAX486: 0.66 ± 0.06, n = 3 coverslips, 7 
neurons, IPA-3: 0.65 ± 0.06, n = 3 coverslips, 10 neurons; One-way ANOVA on 
Ranks p = 0.397, Figure 5.6 and Figure 5.7). These results suggest that 
incubation of hippocampal neurons with Group I PAK inhibitors do not produce 
striking morphological changes on dendritic protrusions. Therefore, LTP inhibition 
produced by IPA-3 may be explained by an activity-dependent effect on 
morphology.  
In a previous study, the overexpression of PAK1 or PAK3 in cultured hippocampal 
neurons resulted in the increase of the number of dendritic spines and in the 
number of clusters of PSD-95 indicative of an increase in excitatory synapse 
formation (Zhang et al., 2005). On the other hand, the expression of the dominant-
negative form of PAK1 or a kinase dead form of PAK3 had the opposite effect: a 
dramatic decrease in dendritic spines and in the number of PSD-95 clusters 
(Zhang et al., 2005). These PAK constructs were expressed in cultured neurons 
for 7 days before analysing the results on neuronal morphology. In our experiment 
cultured neurons were incubated with PAK inhibitors for only 2 – 2.5 hours prior to 




dendritic spine morphology observed in our experiments might be due to 






Figure 5.6 PAK inhibition does not affect basal dendritic
spine morphology. Primary cultured hippocampal neurons
(DIV 14-29) were incubated with vehicle (DMSO), IPA-3 (25
µM), or FRAX486 (500 nM) before fixing and staining with
phalloidin (Control: 0.53± 0.05 Area(µm2) n = 3 coverslips, 8
neurons; FRAX486: 0.66 ± 0.06, n = 3 coverslips, 7 neurons,
(IPA-3: 0.65 ± 0.06, n = 3 coverslips, 10 neurons; One-way






Figure 5.7 Quantification of dendritic spine area
reveals no changes produced by Group I PAK
inhibitors. Primary cultured hippocampal neurons (DIV 14-
29) were incubated with vehicle (DMSO), IPA-3 (25 µM), or
FRAX486 (500 nM) before fixing and staining with




5.3.4 A chemical-LTP stimulus in conjunction with Group I PAK inhibition reduces 
dendritic spine size 
There are structural changes following glutamate uncaging (Matsuzaki et al., 
2004), high-frequency electrical stimulation or theta-burst stimulation. LTP 
increases F-actin content which suggests that spine enlargement requires actin 
polymerization (L. Y. Chen et al., 2007; Fukazawa et al., 2003). LTP is impaired 
when cytoskeletal actin assembly is blocked (Fukazawa et al., 2003; Kim & 
Lisman, 1999). PAK proteins are involved in molecular cascades that mediate 
spine morphology via cofilin, an actin depolymerizing protein (L. Y. Chen et al., 
2007). PAK phosphorylation activates its kinase activity, and this has been 
observed shortly after LTP induction (L. Y. Chen et al., 2007). As in previous 
experiments we found that inhibition of PAK blocked LTP induction but not 
maintenance we hypothesized that inhibition of PAK may block actin 
polymerization necessary for LTP.  
Previously, bath application of glycine was found to promote dendritic spine 
growth (Groc et al., 2008; W. Y. Lu et al., 2001; Shahi & Baudry, 1993). Therefore, 
we analysed whether F-actin stained protrusions on dendrites of cultured 
hippocampal neurons were larger in neurons treated with glycine and whether 
group I PAK inhibitors would inhibit glycine-induced growth. Primary cultured 
hippocampal neurons (DIV 21) were treated with aCSF without glycine (control), 
aCSF with glycine (200 µM). In addition, two sets of neurons were pre-incubated 
with group I PAK inhibitors IPA-3 or FRAX486 for 1.5 – 2 hours before incubating 
them with aCSF + glycine (200 µM) + IPA-3 (25 µM), and aCSF + glycine (200 
µM) + FRAX486 (500 nM), respectively.  
Figure 5.8 shows representative images of F-actin stained neurons. As the data 
failed the Equal Variance Test, we analysed whether there were statistical 
differences between the groups using Kruskal-Wallis statistical test. Quantitative 
analysis of the area of individual protrusions indicate that there is no significant 
difference between groups (Control: 0.53 ± 0.05 Area(µm2), n = 3 coverslips, 8 




0.09, n = 2 coverslips, 4 neurons, Gly+IPA-3: 0.38 ± 0.04, n = 3 coverslips, 4 
neurons, Figure 5.8 and Figure 5.9). The results from glycine treated neurons 
were highly variable. However, there was a significant difference between groups 
that were pre-incubated with IPA-3 and FRAX486, while data from other 
measurements, such as protrusion shape and number of protrusions analysed per 
10 µm2 were homogenous. These results suggest that IPA-3 and FRAX486 have 
distinct pharmacological actions on neurons, IPA-3 seems to reduce dendritic 
spine growth while FRAX486 does not. These results are consistent with our 
previous results in which IPA-3 incubation and perfusion hampers LTP whilst 
FRAX486 incubation and perfusion does not. 
One of the limitations of this experiment is that the protrusions are close to the 
resolving limit of wide-field microscopy fluorescence imaging. The contrast and 
spatial resolution are affected by light scattering of approximately 250 nm 
(laterally) (Chazeau & Giannone, 2016) while the diameter of the largest spine 
heads, mushroom spine heads, measures up to 1 µm and spine neck diameter 
ranges from 100 to 200 nm (Fiala et al., 2002). Accordingly, these limitations might 
prevent accurate observation and measurements of structural changes, indicating 







Figure 5.8 Group I PAK inhibition causes dendritic spine
morphology alterations in primary cultured hippocampal
neurons. Top left: control neuron incubated with aCSF for 10
minutes. Top right: neuron treated with Glycine (200 µM) tor
10 minutes. Bottom Left: neuron incubated with aCSF with
Glycine (200 µM) for 10 minutes following preincubation with
IPA-3 (25 µM). Bottom right: neuron pre-incubated with
FRAX486 and treated with aCSF + Glycine (200 µM) tor 10






















































Figure 5.9 Different Group I PAK inhibitors produce
distinct effects on structural plasticity. Area (µm2):
Control: 0.53± 0.05, n = 3 coverslips, 8 neurons, Gly: 0.65
± 0.05, n = 9 coverslips, 15 neurons, FRAX486+Gly: 0.79
± 0.09, n = 2 coverslips, 4 neurons, Gly+IPA-3: 0.38 ±
0.04, n = 3 coverslips, 4 neurons. Data shown as mean ±


















































































































5.3.5 Chemical LTP induces GluA2-AMPAR synaptic expression 
The heteromeric AMPARs containing GluA1/GluA2 and GluA2/GluA3 are the 
most commonly expressed in adult neurons in the CA1 region of the hippocampus, 
whereas only 8% of total AMPARs are homomeric GluA1 receptors (Lu et al., 
2009; Wenthold et al., 1996). A substantial body of evidence suggests that the 
recruitment of additional AMPARs to the synaptic surface is necessary for LTP 
(Granger & Nicoll, 2014; Penn et al., 2017). The reason behind the impairment of 
LTP observed following inhibition of Group I PAK using IPA-3 might be explained 
by a reduction in activity-dependent AMPAR recruitment to the synapse. 
Therefore, in order to identify a method to test the mechanism by which Group I 
PAK inhibition impairs LTP, we tested a different stimulation protocol found to 
produce an increased amount of synaptic surface AMPARs (Groc et al., 2008; Lu 
et al., 2001). 
First, we aimed to test whether the chemical LTP (chemLTP) protocol consisting 
of a 3-min application of glycine (200 µM) and picrotoxin (1 µM) elicited significant 
changes in GluA2-AMPAR expression at the synapse. We observed that Gly/Pic 
increased GluA2-AMPAR density at the synapse (Control: 967 ± 396 
Intensity/Area(pixels), n = 2 coverslips, 3 neurons; Gly: 1867 ± 342, n = 2 
coverslips 4 neurons, KS statistic = 0.1563, p = 0.0003, Figure 5.10 and Figure 
5.11). This result indicates that cLTP could be used to test whether preincubation 
with Group I PAK inhibitors prevent the activity-dependent increase of surface 
GluA2-AMPARs at the synapse, thereby providing a method to test the 
mechanism involved in IPA-3-mediated LTP impairment.  
One limitation is that we did not test the specificity of the GluA2 antibody. If the 
specificity of the GluA2 antibody is low, then it means that the antibody might not 
have recognised the target protein correctly or that there was non-specific binding 
with other proteins and therefore our GluA2-containing AMPAR quantification 
would be inaccurate. For future experiments, it would be useful to test the GluA2-
antibody specificity by omitting this anti-GluA2 primary antibody, and by using 




anti-GluA2 antibody we used for this experiment has been previously used by 
other researchers in immunocytochemistry experiments to stain receptors in 
dissociated neuronal cultures from mice and rats (Ho et al., 2014; Vazquez-
Sanroman et al., 2015). 
Future experiments should examine whether the GluA1-containing AMPARs 
recruitment to the synaptic surface are dysregulated by PAK inhibition as LTP 
induction triggers the trafficking of GluA1 homomers to the synapse, but these 
receptors remain there transiently before they are replaced by GluA2-containing 





Figure 5.10 ChemLTP increases GluA2-AMPAR subunits
on the dendritic spine surface of primary cultured
hippocampal neurons. Top left: example of control neuron
incubated in aCSF for 10 minutes. Middle: example of neuron
incubated in aCSF with Glycine (200 µM) for 10 minutes.
Right: example of neuron preincubated with AP5 before
treating with aCSF and Glycine (200 uM) for 10 minutes.
Bottom: examples of analysed ROIs of dendritic branches of





Figure 5.11 Effect of glycine on the content of synaptic
GluA2-AMPARs. Distributions of the synaptic density of
GluA2-AMPARs. Top: control (average Fluorescence
Intensity/Area(pixels): 967± 396, n = 2 coverslips, 3 neurons).
Middle: 10 minutes after glycine application (average: 1867 ±
342, n = 2 coverslips, 4 neurons; Kolmogorov-Smirnov statistic
= 0.1563, p = 0.0003 compared to control). Bottom: 10
minutes after glycine application in neurons preincubated with





















5.3.6 Chemical LTP is dependent on NMDAR function 
Importantly, induction of LTP in the area CA1 of the hippocampus is dependent 
on NMDAR activation (Bliss & Collingridge, 1993). Our results thus far indicate 
that we could test whether Group I PAK inhibition by IPA-3 impairment of LTP is 
mediated by reduced synaptic AMPAR expression. However, we first aimed to 
assess whether chemLTP stimulation-mediated increase in synaptic surface 
GluA2-AMPARs is dependent on NMDAR activation. In order to test this, we 
incubated cultured hippocampal neurons with the NMDAR inhibitor AP5 (50 µM) 
before applying the chemLTP stimulus. Incubation of AP5 prior to chemLTP 
stimulus prevented the significant increase of synaptic surface GluA2-AMPARs 
observed with the chemLTP stimulus alone (Control: 967 ± 396 
Intensity/Area(pixels), n = 2 coverslips, 3 neurons, Gly: 1867 ± 342, n = 2 
coverslips, 4 neurons, AP5: 767 ± 118, n = 2 coverslips 4 neurons, ANOVA on 
Ranks p = 0.001, Figure 5.10 and Figure 5.11). These findings provide support 
for the use of chemLTP as a method to assess whether Group I PAK inhibition of 
LTP might be mediated by reduced AMPAR recruitment to the synapse.  
 
5.4 Discussion 
5.4.1 PAK inhibition does not change the fEPSP waveform 
Detailed analysis of fEPSP waveform kinetics have been used to determine if 
there are differences in synaptic integration between groups of neurons (Petersen 
et al., 2013). Therefore, we analysed fEPSP waveform parameters to assess 
whether there were changes in synaptic integration in untreated (control) slices 
and slices treated with the Group I PAK inhibitor IPA-3. However, the only 
significant changes observed were in the values of peak latency of control slices 
after LTP induction. This was expected as the responses measured in control 
slices underwent potentiation, measured by increased fEPSP slope values which 




One limitation of this analysis is that we did not properly assess the kinetics of the 
decay phase of the fEPSP responses. This could be done by using a curve fitting 
function to determine if there were differences in the rate of decay between 
fEPSPs from controls and IPA-3. It was found that NMDAR-mediated currents 
show a biexponential decay phase in dentate granule cells in rat hippocampal 
slices (Keller et al., 1991). Therefore, further work should include this analysis as 
it may provide an estimate for testing whether postsynaptic receptor NMDAR 
open-channel properties in the area CA1 of the hippocampus also decay 
biexponentially, and if their properties are modified by PAK inhibition. 
5.4.2 Calcium signalling and PAK inhibition 
Calcium influx through NMDARs is essential for the initiation of biochemical 
cascades that induce LTP and dendritic spine structural changes (Kennedy et al., 
2005). If inhibition of Group I PAKs resulted in dysregulation of Ca2+ influx, then 
the signalling cascades necessary to induce LTP would be altered, consequently 
this result would explain LTP impairment caused by the Group I PAK inhibitor IPA-
3. To test whether Group I PAK inhibition resulted in Ca2+ dysregulation, we 
analysed intracellular Ca2+ changes using the Ca2+ indicator Flou4-AM. However, 
our results suggest that perfusion of neither IPA-3 nor FRAX486, Group I PAK 
inhibitors produced significant changes in intracellular Ca2+, while perfusion of KCl 
which produces neuronal depolarisation led to an immediate increase in 
intracellular Ca2+. Thus, the inhibition of LTP mediated by IPA-3 cannot be 
explained by dysregulated Ca2+ signals.  
One limitation of these experimental protocol is that PAK inhibition-mediated LTP 
impairment may specifically affect dendritic spine Ca2+ signals, as these structures 
have been hypothesised to be isolated signalling compartments (Bloodgood et al., 
2009; Müller & Connor, 1991). However, our results were taken as measurements 
of intracellular Ca2+ concentration from the soma of cultured hippocampal 
neurons. It is now possible to image Ca2+ signalling in dendritic spine heads using 
two-photon laser scanning microscopy, glutamate uncaging and Ca2+-indicators 




mimics neurotransmitter release from presynaptic inputs, using this paradigm in 
future studies may provide a better estimate of Ca2+ concentration changes in 
order to assess whether inhibition of Group I PAKs dysregulates Ca2+ signalling. 
5.4.3 Chemical LTP: a model for rapid pharmacological assays 
Although the labelling and imaging methods used in this study to asses spine 
morphology changes were not sufficiently sensitive, our results suggest that 
Group I PAKs are involved in chemLTP-induced morphology changes. However, 
whether PAKs are also involved in the accumulation of AMPARs at the synaptic 
surface is still unclear. Our results using chemLTP to assess the expression of 
GluA2 at the synaptic surface suggest that the protocol used might be a useful 
protocol to assess whether PAKs are involved in AMPAR trafficking to the 
synapse. Therefore, future work should focus on determining whether Group I 
PAKs mediate the expression of AMPAR GluA2 or GluA1 subunits using the 
chemLTP and GluA subunit labelling protocol. As AMPAR incorporation at 
postsynaptic sites is crucial for LTP induction (Granger et al., 2013), the results of 
the aforementioned future experiments may explain how Group I PAK inhibition 
results in LTP impairment. 
These data must be interpreted with caution because we did not confirm 
experimentally if chemLTP was induced in cultured neurons. Several reports have 
shown that glycine stimulation leads to activation of NMDARs, increase in 
intracellular calcium, activation of CaMKII, insertion of AMPARs at the synaptic 
surface, in addition to enhanced amplitude and frequency of mEPSCs (Lu et al., 
2001; Molnár, 2011). We confirmed that glycine stimulation was followed by an 
increased in synaptic GluA2-containing AMPARs, and that this effect was 
dependent on NMDAR activation.  
However, future investigations could confirm whether chemLTP was induced in 
cultured neurons by measuring whether intracellular calcium is increased following 
glycine stimulation using the calcium indicator Fluo-4AM; the activation of CaMKII 




the increase in surface AMPAR at the synapse (Matsuzaki et al., 2004; Steiner et 
al., 2008), or by identifying whether glycine stimulation increases CaMKII 
autophosphorylation at Thr286 (Oh & Derkach, 2005); The insertion of GluA1-
containing AMPARs at the synaptic surface by staining cultured hippocampal 
neurons with an anti-GluA1 antibody against the amino-terminal extracellular 
epitope under non-permeant conditions and measuring colocalization with a 
synaptic marker; Finally, we could also measure whether the frequency and 
amplitude of mEPSCs are increased following glycine perfusion (Lu et al., 2001).  
Another limitation is that the cultured hippocampal neurons used in these 
experiments were not preconditioned with the NMDAR antagonist APV prior to 
glycine stimulation. The presence of APV in the growth medium promotes the 
upregulation of NMDARs and when the antagonist is removed, glycine application 
enhances the activation of NMDARs (Molnár, 2011). Further research should be 
undertaken to investigate the effects of PAK inhibition on dendritic spine 
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Chapter 6 – General discussion 
6.1 Summary of the results 
 
In Chapter 3, we analysed the effects of Aβ and α-synuclein oligomerisation on 
LTP impairment. The results of this chapter suggest that a sufficient amount of 
oligomerisation is required to inhibit LTP. Additionally, the pathophysiology of Aβ 
and α-synuclein may be different as the canonical GSK-3β pathway triggered by 
Aβ was not involved in α-synuclein mediated pathogenesis on LTP. Finally, when 
oligomers from different sources are found together their adverse effects are 
magnified. 
In Chapter 4, Group I PAKs were found to have a role in LTP induction, although 
different inhibitors produced different results. While analysing the mechanisms 
underlying the effect of PAKs on LTP, we found that inhibition of Group I PAKs do 
not interfere with the level of depolarisation resulting from tetanic stimulation. 
Furthermore, artificially stimulating Group I PAKs activator Cdc42 using bradykinin 
did not affect LTP.  
In Chapter 5, we aimed to test whether PAK inhibition affects the molecular signals 
required for LTP induction. It was found that PAK inhibitors do not alter intracellular 
calcium concentration. Our results show that Group I PAKs are involved in activity-
induced morphology changes in dendritic spines. Furthermore, the chemLTP 
protocol used in this study results in increased GluA2-AMPARs at the synaptic 
surface, making it a good protocol to test whether PAKs are involved in AMPAR 






6.2 The role of PAKs in synaptic plasticity: regulation of receptors or structure? 
 
In this study, it was found that applying the PAK inhibitor IPA-3 only blocked LTP 
at certain time-points which suggests that the target of PAKs is required for certain 
parts of the LTP process. This is consistent with the findings of Murakoshi et al 
2011. In this paper, they found that sLTP has two phases: a transient phase and 
a sustained phase where RhoGTPases were activated Rho, Rac1 and Cdc42. 
Additionally, when PAK was inhibited only the sustained phase was affected. 
These findings suggest that PAK function allows LTP to progress into subsequent 
steps. However, the specific targets or function of PAKs on components of the 
signalling cascades leading to LTP expression is still unclear.  
 
To explore the possible specific functions of PAKs cultured hippocampal neurons 
were used instead of hippocampal slices to analyse a larger proportion of 
synapses in a simpler system. First, we measured intracellular calcium 
concentration as the influx of calcium is essential for CaMKII activation and LTP 
induction. We found that PAK inhibitors do not alter calcium influx. However, these 
results were obtained by studying neurons under basal conditions and future work 
should test the effects of PAK inhibition on calcium uptake following activation. 
The next step was to assess the effects of PAKs on activity-induced morphology 
changes in dendritic spines, as PAKs are known regulators of the actin 
cytoskeleton. To do this, we used a chemLTP protocol consisting of bath 
application of glycine and picrotoxin to cultured hippocampal neurons known to 
produce spine enlargement. Our results suggest that PAK inhibition reduce spine 
growth triggered by chemLTP. This result is consistent with other studies 
demonstrating a role of PAKs on activity-dependent dendritic spine morphology 
changes. Indeed, structural modification is thought to be required for the 
expression of plasticity as blocking actin polymerisation impairs LTP (Fukazawa 




(Matsuzaki et al., 2004; Okamoto et al., 2004). Therefore, this role of PAKs in the 
regulation of the actin cytoskeleton could link them with plasticity regulation.  
 
In addition, we explored the involvement of PAKs in AMPAR trafficking.  We 
observed that the induction of chemLTP resulted in increased GluA2-AMPARs at 
the synaptic surface, which was dependent on NMDAR activation. Our results are 
consistent with experiments that observed an increase in GluA2 labelling at the 
PSD in response to a similar glycine-based chemLTP stimulation protocol (Tao-
Cheng et al., 2011). However, we did not test the effect of PAK inhibition on 
AMPAR trafficking. Therefore, the problem we cannot conclude from our results 
that PAK inhibition interferes with AMPAR exocytosis. Nevertheless, there is 
evidence that glycine stimulation enhances GluA1 and GluA2 trafficking into 
spines, via a Rac1-PAK-LIMK-dependent pathway (Fortin et al., 2010). Therefore, 
these findings suggest that PAK might have a role in AMPAR trafficking necessary 
for NMDAR-dependent LTP.  
 
One possible explanation for the involvement of PAKs in receptor trafficking is that 
PAK may be required for the proper function of other proteins involved in 
exocytosis. Direct evidence suggesting that the source of AMPARs mobilised 
during LTP are transported from endosomes to the synaptic membrane came from 
studies by Park et al. (2004, 2006). The small GTPase Rab11a and Rme1 are 
proteins required for recycling endosome transport. The expression of dominant 
negative forms of Rab11a and Rme1 prevented transport from recycling 
endosomes resulting in the inhibition of glycine-dependent increase in AMPARs 
at the synaptic surface (Park et al., 2004, 2006). Moreover, blocking SNARE-
complex dependent recycling endosome fusion to the plasma membrane by the 
expression of a transmembrane domain lacking syntaxin13 (syn13ΔTM) abolishes 
glycine-induced AMPAR exocytosis, spine growth and LTP (Park et al., 2004, 
2006). And, exocytosis in spines not only provides a method to transport proteins 




expand the spine surface area (Patterson & Yasuda, 2011). These results suggest 
that LTP stimuli increase recycling endosome trafficking to the plasma membrane, 
which is necessary for spine growth and increased AMPAR-mediated synaptic 
transmission. 
 
Turning now to more specific mediators of AMPAR exocytosis during LTP, the 
insertion of GluA-1 containing AMPARs into the plasma membrane in response to 
glutamate uncaging was found to be mediated by the small GTPase Ras-Raf-
MEK-ERK pathway (Patterson et al., 2010). In addition, the Ras signalling 
pathway drives AMPAR delivery to the plasma membrane during LTP. A study by 
Zhu et al., showed that the expression of constitutively active Ras mimics LTP by 
enhancing AMPAR-mediated synaptic transmission, whereas neurons expressing 
the dominant negative form of Ras did not exhibit pairing-induced LTP. 
Furthermore, it was reported that pairing-induced LTP was blocked by a MEK 
inhibitor (Zhu et al., 2002). Returning to the issue of the role of PAKs in exocytosis, 
PAKs could have an influence in Ras-mediated trafficking of receptors as it has 
been reported that PAK activates Raf1 (King et al., 1998) and MEK1 (Frost et al., 
1997). Therefore, these findings suggest the existence of biochemical pathways 
linking PAK activity with AMPAR trafficking to the synapse which is associated 
with both functional and structural LTP.  
 
Another interesting point to note that one member of the Group I PAKs was found 
to be involved in regulating glutamate receptor trafficking. In a study by Hussein 
et al. a previously unknown GluA1-AMPAR subunit phosphorylation site serine 
863 (S863) was found to regulate GluA1 trafficking. The specific signalling 
pathway is triggered by EphB2 receptor activation, where EphB2 interacts with a 
guanine nucleotide exchange factor (Zizimin1) that activates Cdc42. This, in turn 
activates PAK3, and ultimately resulting in phosphorylation of S863 by PAK3 
(Hussain et al., 2015). Recruitment of glutamate receptors to the postsynaptic 




AMPAR trafficking to the synapse inhibits synaptic potentiation (Granger & Nicoll, 
2014; Penn et al., 2017). Therefore, these findings provide supporting evidence 
for the existence of a link between PAKs with synaptic plasticity through the 
regulation of AMPAR trafficking.  
Furthermore, a possible role for PAK is the maintenance of RhoGTPase activity 
to mediate local protein synthesis which sustains LTP. RhoGTPases are activated 
by guanine nucleotide exchange factors (GEFs). It was found that PAK forms 
binds to α and β-PAK-interacting GEFs (αPIX and βPIX) which drives activation 
of Rac1 or Cdc42 (Manser et al., 1998). In turn, the scaffolding protein Shank was 
reported to form a complex with βPIX and PAK (Park et al., 2003). And, in a study 
by Saneyoshi et al. showed that the overexpression of Shank led to an increase 
of  phosphorylated βPIX and PAK in dendritic spines. In the same study, the 
inhibition of NMDAR activity suppressed the phosphorylation of βPIX and the 
activation of Rac1, which resulted in decreased spine density. The effects of 
inhibiting this pathway were prevented by the expression of a constitutively active 
PAK1 (Saneyoshi et al., 2008). Furthermore, activation of Rac1 activates the 
PI3K-Akt-mTOR pathway which regulates ribosomal translation. This pathway 
may drive local dendritic protein synthesis necessary to stabilise LTP (Kennedy et 
al., 2005; Klann & Dever, 2004). Therefore, it might be the case that once PAKs 
form complexes with PIX and binds to Rac1 the complex retains its activation, and 
that produces local protein synthesis necessary for LTP.   
 
An important limitation of this study was that we did not assess the effects of 
chemLTP on the delivery of GluA2-lacking AMPARs to the synaptic surface and 
whether PAK inhibition affected it. This is an important issue as trafficking of 
GluA2-lacking AMPARs to the synapse is crucial for LTP induction and as 
previously discussed, PAKs could be involved in AMPAR exocytosis (Y. Hayashi 
et al., 2000; Zamanillo et al., 1999). The omission of this experiment means that 
we cannot definitively link PAK function with AMPAR trafficking. However, given 




prevents LTP expression a likely explanation still remains a mechanistic 
relationship between PAK and glutamate receptor regulation. 
 
The next limitation is that we only assessed hippocampal samples. Synaptic 
plasticity occurs in other areas, e.g., the motor cortex, the visual cortex, and the 
amygdala (De Pasquale et al., 2014; Iriki et al., 1989; Maren, 1999). Indeed, PAK 
is located in different regions not only the hippocampus (Koth et al., 2014). 
Therefore, whilst we can only argue with some certainty that PAK is required for 
LTP in the hippocampus whether its role extends to plasticity in other regions 
remains to be shown.  
 
Finally, another limitation is that we only used pharmacological compounds to 
inhibit PAKs, therefore cannot account for possible off target effects of the 
inhibitors used. For instance, it was assumed that IPA-3 blocked LTP but another 
unknown factor affected by the inhibitor may have mediated the LTP inhibition 
effect. Alternatively, studies genetically manipulation by shRNA and transgenic 
animals to target a specific PAK family member have also reported that both PAK1 
and PAK3 impair LTP (Asrar et al., 2009; Meng et al., 2005). Research using 
shRNA and transgenic tools are more specific, but they also have the 
disadvantage of the possibility of compensation by other PAK isoforms. Whilst our 
approach has limitations, its advantage is that it allowed us to block PAKs at 
different stages of LTP induction through extracellular perfusion. Therefore, our 
approach targeted PAKs directly and to test effects at different timepoints which 
could not have been achieved by genetic manipulation.   
 
In conclusion, LTP is a complex process that is triggered by a combination of a 
plethora of postsynaptic events that lead to actin cytoskeleton rearrangements 
and AMPAR trafficking to synaptic surfaces, among others (Cingolani & Goda, 




PAKs are involved in a dual-pathway, where they, in plasticity, are required for 
both the trafficking of receptors and synapse remodelling.  
 
6.3 PAKs in synaptic regulation and possible therapeutic translation for dementia  
 
In this study Group I PAKs were found to be necessary for synaptic plasticity and 
involved in dendritic spine structural changes, given that inhibition of Group I PAKs 
impaired LTP and chemLTP-associated spine enlargement. However, we did not 
assess the effects of PAKs in under pathological conditions.  
PAK has previously been shown to be critical in postnatal growth and attainment 
of normal brain size and function in mice (Huang et al., 2011). It has also been 
reported to participate in spine stabilisation and spine growth associated with 
learning (Dubos et al., 2012). Arsenault et al. postulate that PAK pathways are 
crucial to the health of synapses and therefore are a likely therapeutic target for 
AD (Arsenault et al., 2013). Accumulating evidence from neuropathological 
studies suggests that synapse loss is a major component of many 
neurodegenerative diseases associated with dementia. Structural changes in 
dendritic spines have been observed in samples from AD patients (Cochran et al., 
2014; DeKosky & Scheff, 1990; Penzes et al., 2011). Although neuronal loss in 
dementia with Lewy bodies is less prevalent than in Parkinson’s disease, animal 
models of α-synucleinopathies suggest that α-synuclein alters dendritic spine 
morphology (Froula et al., 2018; Kramer & Schulz-Schaeffer, 2007). Interestingly, 
a study found that PAK4 has a neuroprotective role for signalling pathways and 
suggested that therefore may be a useful therapeutic target for PD (Won et al., 
2016). 
Collectively, these findings indicate that more research needs to be done to 
understand the role of PAKs in the context of neurodegenerative disorders.  This 




negatively with cognitive ability (Terry et al., 1991). Therefore, the understanding 
of the roles of PAKs could offer a unique way to find therapies address both 
synapse loss and synapse dysfunction. 
 
6.4 Conclusion  
 
In general, these experiments have confirmed that neurodegeneration is likely 
produced by aggregated protein oligomers which may trigger various adverse 
signalling cascades resulting in alterations in synaptic function and structure. In 
addition, we found that Group I PAK proteins are involved in both synaptic 
plasticity and synaptic morphology changes. This makes Group I PAKs key targets 
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